data_1g5v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1g5v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 8.5999999999999996 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.710000000000001 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.42 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 9.0099999999999998 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.8099999999999996 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.4399999999999995 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 6.0999999999999996 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.4699999999999998 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.5999999999999996 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 10.73 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.2400000000000002 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.449999999999999 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.8200000000000003 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.630000000000001 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 9.1400000000000006 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.2800000000000002 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 7.4000000000000004 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7000000000000002 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.7699999999999996 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.3100000000000005 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 122' ' ' THR . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.640000000000001 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.609999999999999 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 17.09 111.077 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.44 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.609999999999999 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 116' ' ' ILE . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.9499999999999993 111.013 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.9900000000000002 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.9100000000000001 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.1900000000000004 111.619 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.658 HG21 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.9000000000000004 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.5899999999999999 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.630000000000001 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.859999999999999 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.5999999999999996 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.658 ' HG2' HG21 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.8099999999999996 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.8600000000000003 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.8600000000000003 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 139' ' ' SER . 37.9 t30 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.9199999999999999 110.72 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 9.3100000000000005 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 137' ' ' ASN . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.6 110.895 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3000000000000007 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.8799999999999999 110.914 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 7.3099999999999996 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.3700000000000001 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 8.5999999999999996 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.710000000000001 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.42 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 9.0099999999999998 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.8099999999999996 110.841 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.4399999999999995 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 6.0999999999999996 110.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.4699999999999998 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.5999999999999996 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 10.73 110.84 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2400000000000002 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.449999999999999 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.8200000000000003 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.630000000000001 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 9.1400000000000006 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.2800000000000002 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 7.4000000000000004 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 116' ' ' ILE . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.7699999999999996 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.3100000000000005 110.822 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.523 HG21 ' N ' ' A' ' 117' ' ' ASP . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.640000000000001 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.523 ' N ' HG21 ' A' ' 116' ' ' ILE . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.609999999999999 110.712 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 17.09 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.44 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.609999999999999 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.9499999999999993 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.9900000000000002 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.9100000000000001 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.1900000000000004 111.409 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.9000000000000004 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.568 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.5899999999999999 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.630000000000001 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.859999999999999 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.5999999999999996 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 10.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.8099999999999996 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.8600000000000003 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.8600000000000003 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 137' ' ' ASN . 1.6 m-80 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.9199999999999999 110.876 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 141' ' ' LEU . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 9.3100000000000005 111.109 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.6 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3000000000000007 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 138' ' ' LEU . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.8799999999999999 110.804 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 7.3099999999999996 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.3700000000000001 110.77 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.996 0.427 . . . . 8.5999999999999996 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.710000000000001 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.42 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 9.0099999999999998 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.8099999999999996 110.816 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.4399999999999995 111.056 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 6.0999999999999996 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.4699999999999998 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.5999999999999996 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 10.73 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.2400000000000002 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.449999999999999 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.565 HG23 HD11 ' A' ' 142' ' ' LEU . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.8200000000000003 110.914 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HB2' ' HG1' ' A' ' 128' ' ' THR . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 9.1400000000000006 112.267 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.2800000000000002 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 7.4000000000000004 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 98' ' ' CYS . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7000000000000002 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.7699999999999996 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.3100000000000005 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 117' ' ' ASP . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.640000000000001 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.609999999999999 109.979 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 116' ' ' ILE . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 17.09 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.44 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.609999999999999 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.9499999999999993 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.9900000000000002 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.9100000000000001 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.1900000000000004 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.9000000000000004 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.5899999999999999 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.434 ' HG1' ' HB2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.630000000000001 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.859999999999999 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.5999999999999996 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 10.0 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.5 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.8099999999999996 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.8600000000000003 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.8600000000000003 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.9199999999999999 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 141' ' ' LEU . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 9.3100000000000005 111.169 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.6 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3000000000000007 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.484 ' HA ' HD22 ' A' ' 141' ' ' LEU . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.8799999999999999 110.778 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.565 HD11 HG23 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 7.3099999999999996 111.02 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.3700000000000001 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.801 0.334 . . . . 8.5999999999999996 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.710000000000001 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.42 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 9.0099999999999998 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.4399999999999995 111.112 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.412 ' SG ' HD12 ' A' ' 113' ' ' ILE . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 6.0999999999999996 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.4699999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.5999999999999996 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.429 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 10.73 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.2400000000000002 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.449999999999999 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.8200000000000003 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.630000000000001 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 9.1400000000000006 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.2800000000000002 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 7.4000000000000004 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' SG ' ' A' ' 98' ' ' CYS . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7000000000000002 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.7699999999999996 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.3100000000000005 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 116' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.640000000000001 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.609999999999999 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 17.09 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.44 110.66 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.609999999999999 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.9499999999999993 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.9900000000000002 111.148 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.9100000000000001 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.1900000000000004 111.455 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.9000000000000004 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.715 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.5899999999999999 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.715 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.630000000000001 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.859999999999999 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.5999999999999996 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 10.0 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.8099999999999996 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.8600000000000003 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.8600000000000003 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.9199999999999999 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HA ' HD12 ' A' ' 141' ' ' LEU . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 9.3100000000000005 111.377 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.6 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3000000000000007 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 138' ' ' LEU . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.8799999999999999 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 7.3099999999999996 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.3700000000000001 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.7 0.286 . . . . 8.5999999999999996 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.710000000000001 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.42 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 9.0099999999999998 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.8099999999999996 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.4399999999999995 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.457 ' HG ' HD23 ' A' ' 141' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 6.0999999999999996 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.4699999999999998 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.5999999999999996 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 10.73 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.2400000000000002 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.449999999999999 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.8200000000000003 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 9.1400000000000006 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.2800000000000002 111.087 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 7.4000000000000004 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7000000000000002 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.7699999999999996 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.3100000000000005 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 117' ' ' ASP . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.640000000000001 110.902 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.568 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.609999999999999 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 17.09 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.44 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.609999999999999 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.9499999999999993 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.704 ' HG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.9900000000000002 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.9100000000000001 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 111.356 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.9000000000000004 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.5899999999999999 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.630000000000001 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.859999999999999 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.5999999999999996 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.717 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.8099999999999996 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.8600000000000003 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.8600000000000003 110.867 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.458 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.9199999999999999 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 9.3100000000000005 111.069 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.6 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3000000000000007 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.704 HD11 ' HG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.8799999999999999 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 7.3099999999999996 110.691 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.3700000000000001 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 8.5999999999999996 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.710000000000001 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.42 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 9.0099999999999998 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.8099999999999996 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.4399999999999995 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.561 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 6.0999999999999996 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.4699999999999998 111.197 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.5999999999999996 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 10.73 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.2400000000000002 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.449999999999999 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 142' ' ' LEU . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.8200000000000003 111.403 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.630000000000001 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 9.1400000000000006 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.2800000000000002 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 7.4000000000000004 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7000000000000002 111.259 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.7699999999999996 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.3100000000000005 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.640000000000001 110.618 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.609999999999999 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 17.09 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.44 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.609999999999999 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.9499999999999993 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.406 ' HG ' HD11 ' A' ' 141' ' ' LEU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.9900000000000002 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.9100000000000001 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.603 HG11 HD22 ' A' ' 141' ' ' LEU . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.1900000000000004 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 127' ' ' TYR . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.9000000000000004 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' N ' HG11 ' A' ' 126' ' ' VAL . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.5899999999999999 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.630000000000001 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.859999999999999 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.5999999999999996 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.713 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 125' ' ' VAL . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.8099999999999996 111.16 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.8600000000000003 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.8600000000000003 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.444 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.9199999999999999 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 141' ' ' LEU . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 9.3100000000000005 110.976 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.6 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.8799999999999999 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 108' ' ' ILE . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 7.3099999999999996 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.3700000000000001 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . 0.496 ' O ' HD13 ' A' ' 116' ' ' ILE . 18.9 m95 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.911 0.386 . . . . 8.5999999999999996 111.124 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.710000000000001 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.42 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 9.0099999999999998 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.8099999999999996 110.878 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.4399999999999995 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 6.0999999999999996 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.4699999999999998 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.5999999999999996 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 10.73 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.2400000000000002 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.449999999999999 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.8200000000000003 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.630000000000001 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 9.1400000000000006 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.2800000000000002 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 7.4000000000000004 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7000000000000002 111.317 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.7699999999999996 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.411 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.3100000000000005 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 117' ' ' ASP . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.640000000000001 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.521 ' N ' HG21 ' A' ' 116' ' ' ILE . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.609999999999999 110.173 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 17.09 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.44 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' HG21 ' A' ' 122' ' ' THR . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.609999999999999 110.974 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 121' ' ' GLU . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.9499999999999993 111.044 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.9900000000000002 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.9100000000000001 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 134' ' ' GLU . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.1900000000000004 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.9000000000000004 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.5899999999999999 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.630000000000001 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.859999999999999 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.5999999999999996 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.489 ' HD2' HG12 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.8099999999999996 111.007 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.8600000000000003 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.8600000000000003 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.9199999999999999 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 141' ' ' LEU . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 9.3100000000000005 111.167 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.6 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3000000000000007 111.08 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 138' ' ' LEU . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.8799999999999999 110.915 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 7.3099999999999996 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.3700000000000001 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.957 0.408 . . . . 8.5999999999999996 111.006 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.710000000000001 110.646 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.42 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 9.0099999999999998 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.8099999999999996 111.03 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.4399999999999995 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 6.0999999999999996 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.4699999999999998 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.5999999999999996 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . 0.432 ' CB ' ' HH ' ' A' ' 127' ' ' TYR . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 10.73 110.493 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.2400000000000002 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.449999999999999 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.8200000000000003 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.630000000000001 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 9.1400000000000006 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.2800000000000002 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 7.4000000000000004 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7000000000000002 111.412 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.7699999999999996 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.3100000000000005 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 116' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.640000000000001 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.609999999999999 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 17.09 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.44 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.609999999999999 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.9499999999999993 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.9900000000000002 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.9100000000000001 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.9000000000000004 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.5899999999999999 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.630000000000001 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.859999999999999 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.5999999999999996 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.8099999999999996 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.8600000000000003 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.8600000000000003 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.9199999999999999 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 9.3100000000000005 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.6 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3000000000000007 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.501 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.8799999999999999 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 7.3099999999999996 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.3700000000000001 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.903 0.382 . . . . 8.5999999999999996 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.710000000000001 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.42 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 9.0099999999999998 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.8099999999999996 110.762 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.4399999999999995 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 6.0999999999999996 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.5999999999999996 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.73 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.2400000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.626 ' HB2' ' HH ' ' A' ' 109' ' ' TYR . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.449999999999999 110.791 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.8200000000000003 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.626 ' HH ' ' HB2' ' A' ' 107' ' ' CYS . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.630000000000001 110.548 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 9.1400000000000006 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.2800000000000002 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 7.4000000000000004 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7000000000000002 111.518 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.7699999999999996 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.3100000000000005 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 117' ' ' ASP . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.640000000000001 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.444 ' N ' HG21 ' A' ' 116' ' ' ILE . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.609999999999999 110.627 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 17.09 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.44 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.609999999999999 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 138' ' ' LEU . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.9499999999999993 111.258 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . 0.543 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.9900000000000002 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.9100000000000001 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.1900000000000004 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.9000000000000004 110.501 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.5899999999999999 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.630000000000001 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.859999999999999 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.5999999999999996 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.815 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.8600000000000003 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.8600000000000003 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.9199999999999999 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.543 ' HG ' ' SG ' ' A' ' 123' ' ' CYS . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 9.3100000000000005 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.6 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3000000000000007 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 123' ' ' CYS . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.8799999999999999 110.75 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 7.3099999999999996 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.3700000000000001 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.861 0.362 . . . . 8.5999999999999996 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.710000000000001 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.42 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 9.0099999999999998 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.8099999999999996 110.98 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.4399999999999995 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 6.0999999999999996 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.4699999999999998 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.5999999999999996 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 10.73 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.2400000000000002 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.449999999999999 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.8200000000000003 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 9.1400000000000006 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.2800000000000002 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 7.4000000000000004 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7000000000000002 111.534 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.7699999999999996 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.574 ' HG ' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.3100000000000005 110.876 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.640000000000001 111.376 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.609999999999999 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 17.09 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.44 110.835 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.609999999999999 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.9499999999999993 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.9900000000000002 110.927 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.574 ' HB ' ' HG ' ' A' ' 115' ' ' SER . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.9100000000000001 110.542 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.1900000000000004 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.9000000000000004 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.5899999999999999 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.630000000000001 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.859999999999999 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.5999999999999996 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 10.0 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.8099999999999996 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.8600000000000003 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.8600000000000003 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.9199999999999999 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 141' ' ' LEU . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 9.3100000000000005 111.176 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.6 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3000000000000007 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 138' ' ' LEU . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.8799999999999999 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 7.3099999999999996 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.3700000000000001 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.587 0.232 . . . . 11.039999999999999 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 59.28 97.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 12.09 110.963 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.85 137.38 43.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 8.5999999999999996 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.710000000000001 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.42 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 9.0099999999999998 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.8099999999999996 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.4399999999999995 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 6.0999999999999996 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.4699999999999998 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.5999999999999996 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 10.73 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.2400000000000002 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.449999999999999 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.8200000000000003 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.630000000000001 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 9.1400000000000006 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.2800000000000002 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 7.4000000000000004 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7000000000000002 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.7699999999999996 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.426 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.3100000000000005 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 122' ' ' THR . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.640000000000001 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.609999999999999 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 17.09 111.077 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.44 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.609999999999999 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.503 ' O ' HG22 ' A' ' 116' ' ' ILE . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.9499999999999993 111.013 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.9900000000000002 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.9100000000000001 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.1900000000000004 111.619 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.658 HG21 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.9000000000000004 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.414 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.5899999999999999 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.414 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.630000000000001 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.859999999999999 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.5999999999999996 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.658 ' HG2' HG21 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 10.0 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.8099999999999996 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.8600000000000003 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.8600000000000003 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.583 HD22 ' HB3' ' A' ' 139' ' ' SER . 37.9 t30 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.9199999999999999 110.72 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 9.3100000000000005 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.583 ' HB3' HD22 ' A' ' 137' ' ' ASN . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.6 110.895 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3000000000000007 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.8799999999999999 110.914 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 7.3099999999999996 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.3700000000000001 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.57 -179.61 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 10.24 111.112 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.886 0.374 . . . . 11.039999999999999 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -130.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 12.09 110.751 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -144.23 123.6 13.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 8.5999999999999996 110.711 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.710000000000001 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.42 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 9.0099999999999998 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.8099999999999996 110.841 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.4399999999999995 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 6.0999999999999996 110.699 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.4699999999999998 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.5999999999999996 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 10.73 110.84 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2400000000000002 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.449999999999999 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.8200000000000003 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.630000000000001 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 9.1400000000000006 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.2800000000000002 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 7.4000000000000004 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 116' ' ' ILE . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.7699999999999996 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.3100000000000005 110.822 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.523 HG21 ' N ' ' A' ' 117' ' ' ASP . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.640000000000001 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.523 ' N ' HG21 ' A' ' 116' ' ' ILE . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.609999999999999 110.712 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 17.09 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.44 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.609999999999999 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.9499999999999993 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.9900000000000002 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.9100000000000001 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.1900000000000004 111.409 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.486 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.9000000000000004 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.568 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.5899999999999999 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.568 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.630000000000001 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.859999999999999 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.5999999999999996 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 10.0 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.8099999999999996 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.8600000000000003 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.8600000000000003 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.417 HD21 ' N ' ' A' ' 137' ' ' ASN . 1.6 m-80 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.9199999999999999 110.876 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.538 ' HA ' HD12 ' A' ' 141' ' ' LEU . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 9.3100000000000005 111.109 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.6 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3000000000000007 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 138' ' ' LEU . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.8799999999999999 110.804 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 7.3099999999999996 110.883 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.437 ' O ' HG12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.3700000000000001 110.77 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo -66.99 93.37 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.437 HG12 ' O ' ' A' ' 143' ' ' SER . 16.5 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 10.24 111.091 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.716 0.293 . . . . 11.039999999999999 110.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -172.17 153.45 3.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 12.09 110.745 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -83.36 122.79 28.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 8.5999999999999996 110.899 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.710000000000001 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.42 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 9.0099999999999998 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.8099999999999996 110.816 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.406 ' HZ1' HG21 ' A' ' 128' ' ' THR . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.4399999999999995 111.056 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 6.0999999999999996 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.4699999999999998 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.5999999999999996 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 10.73 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.2400000000000002 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.449999999999999 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.565 HG23 HD11 ' A' ' 142' ' ' LEU . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.8200000000000003 110.914 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.630000000000001 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HB2' ' HG1' ' A' ' 128' ' ' THR . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 9.1400000000000006 112.267 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.502 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.2800000000000002 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 7.4000000000000004 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 98' ' ' CYS . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7000000000000002 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.7699999999999996 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.3100000000000005 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.554 HG22 ' N ' ' A' ' 117' ' ' ASP . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.640000000000001 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.554 ' N ' HG22 ' A' ' 116' ' ' ILE . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.609999999999999 109.979 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.432 ' HE1' HG21 ' A' ' 116' ' ' ILE . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 17.09 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.44 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.609999999999999 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.9499999999999993 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.9900000000000002 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.9100000000000001 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.1900000000000004 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.611 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.9000000000000004 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.5899999999999999 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.434 ' HG1' ' HB2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.435 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.630000000000001 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.859999999999999 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.5999999999999996 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.611 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 10.0 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.5 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.8099999999999996 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.8600000000000003 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.443 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.8600000000000003 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.9199999999999999 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.415 HD23 HD13 ' A' ' 141' ' ' LEU . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 9.3100000000000005 111.169 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.6 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3000000000000007 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.484 ' HA ' HD22 ' A' ' 141' ' ' LEU . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.8799999999999999 110.778 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.565 HD11 HG23 ' A' ' 108' ' ' ILE . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 7.3099999999999996 111.02 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.3700000000000001 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.72 -79.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 10.24 111.212 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.689 0.28 . . . . 11.039999999999999 110.805 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.5 113.18 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 12.09 111.037 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -78.92 135.53 37.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 8.5999999999999996 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.710000000000001 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.42 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 9.0099999999999998 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.4399999999999995 111.112 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.412 ' SG ' HD12 ' A' ' 113' ' ' ILE . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 6.0999999999999996 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.4699999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.5999999999999996 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.429 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 10.73 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.2400000000000002 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.449999999999999 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.8200000000000003 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.630000000000001 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 9.1400000000000006 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.2800000000000002 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 7.4000000000000004 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.412 HD12 ' SG ' ' A' ' 98' ' ' CYS . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7000000000000002 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.7699999999999996 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.3100000000000005 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.416 HG22 HD13 ' A' ' 116' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.640000000000001 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.609999999999999 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 17.09 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.44 110.66 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.609999999999999 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.9499999999999993 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.9900000000000002 111.148 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.9100000000000001 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.1900000000000004 111.455 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.9000000000000004 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.715 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.5899999999999999 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.715 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.630000000000001 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.859999999999999 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.5999999999999996 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 10.0 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.8099999999999996 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.8600000000000003 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.8600000000000003 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.9199999999999999 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' HA ' HD12 ' A' ' 141' ' ' LEU . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 9.3100000000000005 111.377 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.6 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3000000000000007 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 138' ' ' LEU . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.8799999999999999 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 7.3099999999999996 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.3700000000000001 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 176.91 2.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 10.24 111.549 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.552 0.215 . . . . 11.039999999999999 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.08 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.13 -0.486 . . . . 12.09 110.897 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -144.67 124.34 13.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 8.5999999999999996 110.97 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.710000000000001 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.42 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 9.0099999999999998 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.8099999999999996 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.4399999999999995 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.457 ' HG ' HD23 ' A' ' 141' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 6.0999999999999996 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.4699999999999998 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.5999999999999996 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 10.73 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.2400000000000002 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.449999999999999 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.8200000000000003 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.630000000000001 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 9.1400000000000006 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.2800000000000002 111.087 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 7.4000000000000004 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7000000000000002 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.7699999999999996 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.3100000000000005 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.568 HG22 ' N ' ' A' ' 117' ' ' ASP . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.640000000000001 110.902 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.568 ' N ' HG22 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.609999999999999 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 17.09 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.44 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.609999999999999 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.9499999999999993 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.704 ' HG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.9900000000000002 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.9100000000000001 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 111.356 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.9000000000000004 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.463 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.5899999999999999 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.463 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.630000000000001 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.859999999999999 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.5999999999999996 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.717 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 10.0 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.8099999999999996 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.8600000000000003 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.458 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.8600000000000003 110.867 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.458 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.9199999999999999 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 9.3100000000000005 111.069 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.6 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3000000000000007 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.704 HD11 ' HG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.8799999999999999 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 7.3099999999999996 110.691 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.3700000000000001 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.22 136.26 19.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.299 -0.409 . . . . 10.24 111.115 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.693 0.282 . . . . 11.039999999999999 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.532 HE21 ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -59.02 161.08 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 12.09 110.956 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -132.72 114.5 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 8.5999999999999996 111.121 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.415 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.710000000000001 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.42 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 9.0099999999999998 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.8099999999999996 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.4399999999999995 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.561 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 6.0999999999999996 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.4699999999999998 111.197 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.5999999999999996 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 10.73 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.2400000000000002 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.449999999999999 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 142' ' ' LEU . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.8200000000000003 111.403 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.630000000000001 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 9.1400000000000006 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.2800000000000002 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 7.4000000000000004 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7000000000000002 111.259 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.7699999999999996 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.3100000000000005 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.640000000000001 110.618 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.609999999999999 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 17.09 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.44 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.609999999999999 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.9499999999999993 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.406 ' HG ' HD11 ' A' ' 141' ' ' LEU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.9900000000000002 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.9100000000000001 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.603 HG11 HD22 ' A' ' 141' ' ' LEU . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.1900000000000004 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.431 HG11 ' N ' ' A' ' 127' ' ' TYR . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.9000000000000004 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.431 ' N ' HG11 ' A' ' 126' ' ' VAL . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.5899999999999999 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.424 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.630000000000001 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.859999999999999 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.5999999999999996 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 10.0 110.713 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 125' ' ' VAL . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.8099999999999996 111.16 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.8600000000000003 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.444 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.8600000000000003 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.444 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.9199999999999999 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 141' ' ' LEU . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 9.3100000000000005 110.976 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.6 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.603 HD22 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.8799999999999999 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 108' ' ' ILE . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 7.3099999999999996 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.3700000000000001 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.561 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo -61.64 125.52 16.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 145' ' ' ILE . 8.4 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 10.24 111.004 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.912 0.387 . . . . 11.039999999999999 111.252 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 143.89 30.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.028 -0.533 . . . . 12.09 111.181 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . 0.496 ' O ' HD13 ' A' ' 116' ' ' ILE . 18.9 m95 -71.02 85.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 8.5999999999999996 111.124 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.710000000000001 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.42 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 9.0099999999999998 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.8099999999999996 110.878 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.4399999999999995 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 6.0999999999999996 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.4699999999999998 111.328 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.5999999999999996 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 10.73 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.2400000000000002 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.449999999999999 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.8200000000000003 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.630000000000001 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 9.1400000000000006 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.2800000000000002 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 7.4000000000000004 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7000000000000002 111.317 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.7699999999999996 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.411 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.3100000000000005 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.521 HG21 ' N ' ' A' ' 117' ' ' ASP . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.640000000000001 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.521 ' N ' HG21 ' A' ' 116' ' ' ILE . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.609999999999999 110.173 179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 17.09 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.44 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' O ' HG21 ' A' ' 122' ' ' THR . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.609999999999999 110.974 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.498 HG21 ' O ' ' A' ' 121' ' ' GLU . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.9499999999999993 111.044 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.499 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.9900000000000002 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.9100000000000001 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 134' ' ' GLU . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.1900000000000004 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.9000000000000004 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.5899999999999999 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.630000000000001 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.859999999999999 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.5999999999999996 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.489 ' HD2' HG12 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 10.0 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 125' ' ' VAL . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.8099999999999996 111.007 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.499 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.8600000000000003 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.8600000000000003 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.9199999999999999 110.879 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.531 ' HA ' HD12 ' A' ' 141' ' ' LEU . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 9.3100000000000005 111.167 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.6 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3000000000000007 111.08 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 138' ' ' LEU . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.8799999999999999 110.915 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 7.3099999999999996 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.3700000000000001 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.92 -35.61 65.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 10.24 110.986 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.574 0.226 . . . . 11.039999999999999 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.68 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.124 -0.489 . . . . 12.09 110.764 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -77.51 116.71 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 8.5999999999999996 111.006 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' C ' HD12 ' A' ' 116' ' ' ILE . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.710000000000001 110.646 179.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.42 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 9.0099999999999998 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.8099999999999996 111.03 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.4399999999999995 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 6.0999999999999996 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.4699999999999998 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.5999999999999996 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . 0.432 ' CB ' ' HH ' ' A' ' 127' ' ' TYR . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 10.73 110.493 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.2400000000000002 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.449999999999999 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.8200000000000003 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.630000000000001 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 9.1400000000000006 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HB3' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.2800000000000002 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 7.4000000000000004 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7000000000000002 111.412 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.7699999999999996 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.3100000000000005 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.409 HD13 HG22 ' A' ' 116' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.640000000000001 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.609999999999999 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 17.09 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.44 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.609999999999999 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.9499999999999993 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.501 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.9900000000000002 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.9100000000000001 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.9000000000000004 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.472 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.5899999999999999 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.630000000000001 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.859999999999999 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.5999999999999996 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 10.0 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.8099999999999996 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.8600000000000003 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.8600000000000003 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.9199999999999999 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 9.3100000000000005 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.6 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3000000000000007 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.501 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.8799999999999999 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 7.3099999999999996 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.537 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.3700000000000001 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo -47.75 131.59 20.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.939 -0.573 . . . . 10.24 111.602 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.446 HE21 ' HB3' ' A' ' 90' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.751 0.31 . . . . 11.039999999999999 110.736 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.14 135.24 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 12.09 110.741 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -89.41 131.46 35.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 8.5999999999999996 111.198 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.710000000000001 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.42 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 9.0099999999999998 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.8099999999999996 110.762 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.4399999999999995 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 6.0999999999999996 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.5999999999999996 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 10.73 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.2400000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.626 ' HB2' ' HH ' ' A' ' 109' ' ' TYR . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.449999999999999 110.791 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.8200000000000003 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.626 ' HH ' ' HB2' ' A' ' 107' ' ' CYS . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.630000000000001 110.548 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.595 ' HB2' HG22 ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 9.1400000000000006 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.2800000000000002 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 7.4000000000000004 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7000000000000002 111.518 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.405 ' O ' HG12 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.7699999999999996 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.3100000000000005 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.444 HG21 ' N ' ' A' ' 117' ' ' ASP . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.640000000000001 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.444 ' N ' HG21 ' A' ' 116' ' ' ILE . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.609999999999999 110.627 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 17.09 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.44 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.609999999999999 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.47 ' O ' HD13 ' A' ' 138' ' ' LEU . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.9499999999999993 111.258 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . 0.543 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.9900000000000002 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.9100000000000001 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.1900000000000004 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.9000000000000004 110.501 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.5899999999999999 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.595 HG22 ' HB2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.630000000000001 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.859999999999999 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.5999999999999996 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 10.0 110.815 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.8600000000000003 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.8600000000000003 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.9199999999999999 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.543 ' HG ' ' SG ' ' A' ' 123' ' ' CYS . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 9.3100000000000005 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.6 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3000000000000007 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.525 HD11 ' SG ' ' A' ' 123' ' ' CYS . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.8799999999999999 110.75 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 7.3099999999999996 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.3700000000000001 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.4 56.33 5.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.384 . . . . 10.24 111.5 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.735 0.303 . . . . 11.039999999999999 111.41 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 50.63 -151.75 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.203 -0.453 . . . . 12.09 111.237 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -149.01 128.22 12.86 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.276 -0.42 . . . . 8.5999999999999996 110.931 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.710000000000001 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.42 110.994 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 9.0099999999999998 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.8099999999999996 110.98 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.4399999999999995 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 6.0999999999999996 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.4699999999999998 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.5999999999999996 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 10.73 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.2400000000000002 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.449999999999999 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.8200000000000003 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.630000000000001 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 9.1400000000000006 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.578 ' HB2' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.2800000000000002 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 7.4000000000000004 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7000000000000002 111.534 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.7699999999999996 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.574 ' HG ' ' HB ' ' A' ' 124' ' ' VAL . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.3100000000000005 110.876 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.640000000000001 111.376 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.609999999999999 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 17.09 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.44 110.835 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.609999999999999 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.9499999999999993 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.9900000000000002 110.927 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.574 ' HB ' ' HG ' ' A' ' 115' ' ' SER . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.9100000000000001 110.542 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.1900000000000004 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.9000000000000004 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.5899999999999999 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . 0.469 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.630000000000001 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.859999999999999 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.5999999999999996 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 10.0 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.8099999999999996 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.8600000000000003 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.8600000000000003 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.9199999999999999 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.518 ' HA ' HD12 ' A' ' 141' ' ' LEU . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 9.3100000000000005 111.176 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.6 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3000000000000007 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 138' ' ' LEU . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.8799999999999999 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 7.3099999999999996 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.3700000000000001 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -162.59 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 145' ' ' ILE . 18.6 tt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 10.24 111.025 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 8.6 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.39 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.15 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 8.2 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.81 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.1 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.47 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.16 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 9.95 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.24 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.07 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.51 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.54 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 8.66 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.22 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 6.83 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.77 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.2 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 115' ' ' SER . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.64 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.56 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 16.87 111.077 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.09 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.61 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.57 111.013 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.82 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.5 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.19 111.619 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.53 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.59 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.436 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.49 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.07 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.58 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 9.35 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.81 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.86 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.86 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.92 110.72 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 8.95 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.26 110.895 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 141' ' ' LEU . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.47 110.914 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 6.92 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.07 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 8.6 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.39 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.15 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 8.2 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.81 110.841 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.1 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 5.76 110.699 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.47 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.16 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.432 ' HA ' ' HH ' ' A' ' 127' ' ' TYR . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 9.95 110.84 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.24 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.07 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.51 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.54 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 8.66 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.22 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 6.83 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.77 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.2 110.822 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 113' ' ' ILE . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.64 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.56 110.712 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 16.87 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.09 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.61 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.57 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.82 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.5 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.771 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.19 111.409 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.53 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.59 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.49 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.07 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.58 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 9.35 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.81 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.86 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.86 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.92 110.876 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 8.95 111.109 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.26 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.47 110.804 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 6.92 110.883 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.07 110.77 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.996 0.427 . . . . 8.6 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.39 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.15 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 8.2 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 113' ' ' ILE . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.81 110.816 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.1 111.056 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 5.76 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.47 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.16 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 9.95 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.24 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.07 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.51 110.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.54 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 8.66 112.267 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.22 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 6.83 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.643 HG21 HD11 ' A' ' 116' ' ' ILE . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.77 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.2 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 113' ' ' ILE . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.64 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.56 109.979 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 16.87 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.09 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.61 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.57 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.82 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.5 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.781 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.19 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.53 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.59 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.49 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.07 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.58 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 9.35 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.81 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.86 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.86 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.92 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 8.95 111.169 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.26 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.47 110.778 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 6.92 111.02 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.07 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.801 0.334 . . . . 8.6 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.39 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.15 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 8.2 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.81 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' NZ ' HG21 ' A' ' 128' ' ' THR . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.1 111.112 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 5.76 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.47 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.16 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . 0.43 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 9.95 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.24 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.07 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.51 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.54 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 8.66 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.22 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 6.83 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.663 HG21 HD11 ' A' ' 116' ' ' ILE . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.77 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.2 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 113' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.64 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.56 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 16.87 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.09 110.66 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.61 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.57 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 141' ' ' LEU . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.82 111.148 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.5 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.19 111.455 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.53 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.746 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.59 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.477 HG21 ' NZ ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.49 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.07 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.58 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 9.35 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.81 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.86 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.86 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.92 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 8.95 111.377 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.26 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 123' ' ' CYS . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.47 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 6.92 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.07 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.7 0.286 . . . . 8.6 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.39 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.15 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 8.2 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.81 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.1 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 5.76 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.47 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.16 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 9.95 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.24 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.07 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.51 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.54 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 8.66 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.22 111.087 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 6.83 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.77 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.2 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.64 110.902 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.56 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 16.87 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.09 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.61 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.57 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.82 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.5 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.471 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.19 111.356 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.53 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.59 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.49 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.07 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.58 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 9.35 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.81 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.86 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.6 tp60 -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.86 110.867 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.92 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 8.95 111.069 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.26 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.47 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 6.92 110.691 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.07 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 8.6 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.39 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.15 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 8.2 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.81 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.1 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.551 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 5.76 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.47 111.197 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.16 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 9.95 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.24 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.07 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.51 111.403 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.54 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 8.66 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.22 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 6.83 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 116' ' ' ILE . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7 111.259 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.77 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.2 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 113' ' ' ILE . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.64 110.618 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.56 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 16.87 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.09 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.61 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.57 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 135' ' ' GLU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.82 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.5 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.19 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 133' ' ' ARG . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.53 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 130' ' ' TYR . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.59 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.49 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.07 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.58 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 9.35 110.713 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.81 111.16 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.86 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.437 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.86 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.92 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 8.95 110.976 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.26 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.47 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 6.92 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.07 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 18.9 m95 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.911 0.386 . . . . 8.6 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.39 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.15 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 8.2 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.488 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.81 110.878 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.1 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 5.76 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.47 111.328 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.16 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.24 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.07 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.51 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.54 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 8.66 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.22 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 6.83 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 96' ' ' ASP . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7 111.317 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.77 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.423 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.2 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 115' ' ' SER . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.64 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.56 110.173 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 16.87 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.09 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.61 110.974 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.57 111.044 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.82 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.5 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.773 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.19 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.53 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.59 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.49 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.07 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.58 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.541 ' HD2' HG13 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 9.35 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.81 111.007 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.86 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.86 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.92 110.879 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 8.95 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.26 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3 111.08 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.47 110.915 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 6.92 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.07 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.957 0.408 . . . . 8.6 111.006 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.39 110.646 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.15 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 8.2 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.77 ' HB3' HD12 ' A' ' 113' ' ' ILE . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.81 111.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.1 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 5.76 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.47 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.16 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 9.95 110.493 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.24 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.07 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.51 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.54 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 8.66 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.22 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 6.83 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 96' ' ' ASP . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7 111.412 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.77 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.2 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 113' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.64 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.56 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 16.87 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.09 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.61 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.57 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.498 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.82 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.5 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.19 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.53 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.59 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.49 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.07 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.58 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 9.35 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.81 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.86 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.86 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.92 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 8.95 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.26 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.47 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 6.92 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.53 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.07 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.903 0.382 . . . . 8.6 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.39 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.15 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 8.2 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.81 110.762 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.1 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 5.76 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.47 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.16 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 9.95 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.24 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.07 110.791 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.51 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.54 110.548 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.483 ' HG2' ' OG1' ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 8.66 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.22 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 6.83 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 116' ' ' ILE . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7 111.518 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.77 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.2 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 138' ' ' LEU . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.64 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.56 110.627 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 16.87 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.09 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.61 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.57 111.258 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.555 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.82 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.5 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.19 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 133' ' ' ARG . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.53 110.501 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.59 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.49 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.07 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.58 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 126' ' ' VAL . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 9.35 110.815 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.81 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.86 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.86 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.92 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 8.95 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.26 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.47 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 6.92 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.07 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.861 0.362 . . . . 8.6 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.39 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 94' ' ' VAL . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.15 110.994 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 8.2 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.609 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.81 110.98 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.1 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 5.76 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.47 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.16 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 9.95 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.24 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.07 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.51 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.54 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 8.66 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.22 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 6.83 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7 111.534 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.77 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.2 110.876 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 113' ' ' ILE . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.64 111.376 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.56 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 16.87 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.09 110.835 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.61 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.57 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.82 110.927 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.5 110.542 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.19 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.53 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.59 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.49 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.07 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.58 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 9.35 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.81 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.86 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.86 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.92 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 8.95 111.176 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.26 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD11 ' SG ' ' A' ' 123' ' ' CYS . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.47 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 6.92 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.07 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.587 0.232 . . . . 10.47 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 59.28 97.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 11.4 110.963 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.85 137.38 43.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 8.6 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.39 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.15 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 8.2 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.81 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.1 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 5.76 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.47 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.16 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 9.95 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.24 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.07 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.51 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.54 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 8.66 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.22 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 6.83 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.77 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.2 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 115' ' ' SER . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.64 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.56 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 16.87 111.077 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.09 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.61 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.57 111.013 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.82 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.5 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.19 111.619 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.53 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.59 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.436 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.49 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.07 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.58 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 9.35 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.81 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.86 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.86 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.92 110.72 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 8.95 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.26 110.895 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 141' ' ' LEU . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.47 110.914 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 6.92 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.07 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.57 -179.61 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 9.94 111.112 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.886 0.374 . . . . 10.47 110.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -130.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 11.4 110.751 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -144.23 123.6 13.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 8.6 110.711 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.39 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.15 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 8.2 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.81 110.841 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.1 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 5.76 110.699 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.47 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.16 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.432 ' HA ' ' HH ' ' A' ' 127' ' ' TYR . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 9.95 110.84 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.24 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.07 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.51 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.54 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 8.66 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.22 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 6.83 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.77 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.2 110.822 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 113' ' ' ILE . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.64 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.56 110.712 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 16.87 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.09 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.61 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.57 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.82 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.5 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.771 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.19 111.409 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.53 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.59 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.49 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.07 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.58 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 9.35 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.81 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.86 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.86 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.92 110.876 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 8.95 111.109 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.26 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.47 110.804 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 6.92 110.883 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.07 110.77 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo -66.99 93.37 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 143' ' ' SER . 16.5 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 9.94 111.091 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.716 0.293 . . . . 10.47 110.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -172.17 153.45 3.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 11.4 110.745 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -83.36 122.79 28.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 8.6 110.899 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.39 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.15 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 8.2 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 113' ' ' ILE . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.81 110.816 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.1 111.056 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 5.76 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.47 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.16 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 9.95 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.24 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.07 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.51 110.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.54 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 8.66 112.267 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.22 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 6.83 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.643 HG21 HD11 ' A' ' 116' ' ' ILE . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.77 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.2 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 113' ' ' ILE . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.64 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.56 109.979 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 16.87 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.09 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.61 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.57 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.82 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.5 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.781 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.19 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.53 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.59 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.49 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.07 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.58 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 9.35 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.81 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.86 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.86 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.92 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 8.95 111.169 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.26 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.47 110.778 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 6.92 111.02 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.07 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.72 -79.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 9.94 111.212 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.3 tm0? . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.689 0.28 . . . . 10.47 110.805 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.5 113.18 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 11.4 111.037 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -78.92 135.53 37.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 8.6 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.39 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.15 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 8.2 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.81 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' NZ ' HG21 ' A' ' 128' ' ' THR . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.1 111.112 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 5.76 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.47 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.16 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . 0.43 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 9.95 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.24 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.07 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.51 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.54 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 8.66 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.22 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 6.83 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.663 HG21 HD11 ' A' ' 116' ' ' ILE . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.77 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.2 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 113' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.64 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.56 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 16.87 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.466 HH11 ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.09 110.66 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.61 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.57 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 141' ' ' LEU . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.82 111.148 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.5 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.19 111.455 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.53 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.746 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.59 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.477 HG21 ' NZ ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.49 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.07 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.58 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 9.35 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.81 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.86 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.86 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.92 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 8.95 111.377 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.26 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 123' ' ' CYS . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.47 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 6.92 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.07 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 176.91 2.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 9.94 111.549 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.552 0.215 . . . . 10.47 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.08 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.13 -0.486 . . . . 11.4 110.897 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -144.67 124.34 13.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 8.6 110.97 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.39 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.15 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 8.2 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.81 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.1 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 5.76 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.47 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.16 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 9.95 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.24 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.07 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.51 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.54 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 8.66 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.22 111.087 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 6.83 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.77 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.2 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.64 110.902 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.56 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 16.87 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.09 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.61 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.57 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.82 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.5 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.471 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.19 111.356 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.53 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.59 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.49 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.07 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.58 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 9.35 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.81 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.86 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.6 tp60 -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.86 110.867 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.92 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 8.95 111.069 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.26 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.47 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 6.92 110.691 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.07 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.22 136.26 19.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.299 -0.409 . . . . 9.94 111.115 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.693 0.282 . . . . 10.47 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.02 161.08 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 11.4 110.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -132.72 114.5 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 8.6 111.121 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.39 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.15 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 8.2 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.81 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.1 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.551 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 5.76 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.47 111.197 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.16 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 9.95 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.24 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.07 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.51 111.403 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.54 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 8.66 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.22 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 6.83 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 116' ' ' ILE . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7 111.259 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.77 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.2 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 113' ' ' ILE . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.64 110.618 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.56 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 16.87 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.09 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.61 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.57 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 135' ' ' GLU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.82 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.5 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.19 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 133' ' ' ARG . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.53 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 130' ' ' TYR . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.59 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.49 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.07 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.58 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 9.35 110.713 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.81 111.16 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.86 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.437 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.86 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.92 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 8.95 110.976 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.26 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.47 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 6.92 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.07 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo -61.64 125.52 16.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 9.94 111.004 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.912 0.387 . . . . 10.47 111.252 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -55.93 143.89 30.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.028 -0.533 . . . . 11.4 111.181 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -71.02 85.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 8.6 111.124 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.39 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.15 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 8.2 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.488 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.81 110.878 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.1 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 5.76 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.47 111.328 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.16 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 9.95 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.24 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.07 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.51 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.54 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 8.66 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.22 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 6.83 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 96' ' ' ASP . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7 111.317 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.77 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.423 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.2 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 115' ' ' SER . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.64 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.56 110.173 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 16.87 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.09 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.61 110.974 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.57 111.044 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.82 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.5 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.773 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.19 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.53 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.59 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.49 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.07 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.58 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.541 ' HD2' HG13 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 9.35 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.81 111.007 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.86 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.86 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.92 110.879 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 8.95 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.26 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3 111.08 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.47 110.915 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 6.92 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.07 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.92 -35.61 65.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 9.94 110.986 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.574 0.226 . . . . 10.47 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.68 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.124 -0.489 . . . . 11.4 110.764 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -77.51 116.71 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 8.6 111.006 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.39 110.646 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.15 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 8.2 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.77 ' HB3' HD12 ' A' ' 113' ' ' ILE . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.81 111.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.1 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 5.76 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.47 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.16 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 9.95 110.493 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.24 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.07 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.51 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.54 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 8.66 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.22 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 6.83 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 96' ' ' ASP . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7 111.412 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.77 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.2 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 113' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.64 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.56 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 16.87 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.09 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.61 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.57 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.498 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.82 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.5 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.19 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.53 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.59 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.49 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.07 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.58 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 9.35 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.81 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.86 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.86 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.92 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 8.95 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.26 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.47 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 6.92 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.53 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.07 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo -47.75 131.59 20.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.939 -0.573 . . . . 9.94 111.602 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.1 tm0? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.751 0.31 . . . . 10.47 110.736 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.14 135.24 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 11.4 110.741 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -89.41 131.46 35.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 8.6 111.198 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.39 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.15 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 8.2 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.81 110.762 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.1 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 5.76 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.47 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.16 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 9.95 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.24 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.07 110.791 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.51 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.54 110.548 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.483 ' HG2' ' OG1' ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 8.66 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.22 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 6.83 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 116' ' ' ILE . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7 111.518 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.77 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.2 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 138' ' ' LEU . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.64 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.56 110.627 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 16.87 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.09 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.61 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.57 111.258 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.555 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.82 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.5 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.19 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 133' ' ' ARG . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.53 110.501 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.59 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.49 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.07 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.58 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 126' ' ' VAL . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 9.35 110.815 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.81 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.86 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.86 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.92 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 8.95 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.26 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.47 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 6.92 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.07 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.4 56.33 5.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.384 . . . . 9.94 111.5 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.735 0.303 . . . . 10.47 111.41 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 50.63 -151.75 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.203 -0.453 . . . . 11.4 111.237 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -149.01 128.22 12.86 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.276 -0.42 . . . . 8.6 110.931 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.39 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 94' ' ' VAL . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.15 110.994 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 8.2 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.609 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.81 110.98 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.1 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 5.76 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.47 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.16 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 9.95 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.24 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.07 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.51 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.54 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 8.66 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.22 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 6.83 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7 111.534 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.77 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.2 110.876 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 113' ' ' ILE . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.64 111.376 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.56 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 16.87 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.09 110.835 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.61 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.57 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.82 110.927 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.5 110.542 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.19 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.53 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.59 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.49 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.07 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.58 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 9.35 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.81 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.86 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.86 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.92 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 8.95 111.176 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.26 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD11 ' SG ' ' A' ' 123' ' ' CYS . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.47 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 6.92 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.07 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -162.59 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 9.94 111.025 179.929 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.814 0.34 . . . . 8.5999999999999996 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.390000000000001 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.15 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 8.1999999999999993 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.8099999999999996 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.0999999999999996 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 5.7599999999999998 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.4699999999999998 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.1600000000000001 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 9.9499999999999993 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.2400000000000002 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.07 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.5099999999999998 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.539999999999999 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 8.6600000000000001 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.2199999999999998 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 6.8300000000000001 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7000000000000002 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.7699999999999996 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.1999999999999993 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 115' ' ' SER . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.640000000000001 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.56 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.473 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 16.870000000000001 111.077 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.09 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.609999999999999 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.5700000000000003 111.013 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.8200000000000003 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.5 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.1900000000000004 111.619 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.5300000000000002 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.5899999999999999 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.436 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.49 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.07 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.5800000000000001 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 9.3499999999999996 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.8099999999999996 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.8600000000000003 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.8600000000000003 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.596 HD21 ' HB3' ' A' ' 139' ' ' SER . 37.9 t30 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.9199999999999999 110.72 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 8.9499999999999993 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 137' ' ' ASN . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.26 110.895 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3000000000000007 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 141' ' ' LEU . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.4699999999999998 110.914 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 6.9199999999999999 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.0700000000000003 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo . . . . . 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 8.5999999999999996 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.390000000000001 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.15 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 8.1999999999999993 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.8099999999999996 110.841 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 5.7599999999999998 110.699 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.4699999999999998 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.1600000000000001 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.432 ' HA ' ' HH ' ' A' ' 127' ' ' TYR . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 9.9499999999999993 110.84 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2400000000000002 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.07 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.5099999999999998 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.539999999999999 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 8.6600000000000001 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.2199999999999998 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 6.8300000000000001 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.7699999999999996 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.1999999999999993 110.822 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 113' ' ' ILE . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.640000000000001 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.56 110.712 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 16.870000000000001 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.09 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.609999999999999 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.5700000000000003 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.8200000000000003 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.5 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.771 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.1900000000000004 111.409 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.5300000000000002 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.5899999999999999 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.49 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.07 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.5800000000000001 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 9.3499999999999996 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.8099999999999996 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.8600000000000003 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.8600000000000003 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 137' ' ' ASN . 1.6 m-80 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.9199999999999999 110.876 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 8.9499999999999993 111.109 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.26 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3000000000000007 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.4699999999999998 110.804 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 6.9199999999999999 110.883 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.0700000000000003 110.77 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo . . . . . 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.996 0.427 . . . . 8.5999999999999996 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.390000000000001 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.15 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 8.1999999999999993 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 113' ' ' ILE . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.8099999999999996 110.816 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.0999999999999996 111.056 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 5.7599999999999998 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.4699999999999998 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.1600000000000001 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 9.9499999999999993 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.2400000000000002 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.07 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.5099999999999998 110.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.539999999999999 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 8.6600000000000001 112.267 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.2199999999999998 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 6.8300000000000001 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.643 HG21 HD11 ' A' ' 116' ' ' ILE . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7000000000000002 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.7699999999999996 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.1999999999999993 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 113' ' ' ILE . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.640000000000001 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.56 109.979 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 16.870000000000001 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.09 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.609999999999999 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.5700000000000003 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.8200000000000003 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.5 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.781 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.1900000000000004 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.5300000000000002 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.5899999999999999 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.49 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.07 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.5800000000000001 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 9.3499999999999996 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.8099999999999996 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.8600000000000003 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.8600000000000003 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.9199999999999999 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 8.9499999999999993 111.169 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.26 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3000000000000007 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.4699999999999998 110.778 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 6.9199999999999999 111.02 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.0700000000000003 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo . . . . . 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.801 0.334 . . . . 8.5999999999999996 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.390000000000001 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.15 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 8.1999999999999993 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.477 ' NZ ' HG21 ' A' ' 128' ' ' THR . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.0999999999999996 111.112 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 5.7599999999999998 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.4699999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.1600000000000001 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . 0.43 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 9.9499999999999993 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.2400000000000002 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.07 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.5099999999999998 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.539999999999999 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 8.6600000000000001 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.2199999999999998 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 6.8300000000000001 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.663 HG21 HD11 ' A' ' 116' ' ' ILE . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7000000000000002 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.7699999999999996 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.1999999999999993 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 113' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.640000000000001 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.56 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 16.870000000000001 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.09 110.66 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.609999999999999 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.5700000000000003 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 141' ' ' LEU . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.8200000000000003 111.148 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.5 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.1900000000000004 111.455 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.5300000000000002 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.746 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.5899999999999999 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.477 HG21 ' NZ ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.49 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.07 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.5800000000000001 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 9.3499999999999996 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.8099999999999996 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.8600000000000003 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.8600000000000003 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.9199999999999999 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 8.9499999999999993 111.377 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.26 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3000000000000007 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 123' ' ' CYS . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.4699999999999998 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 6.9199999999999999 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.0700000000000003 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 120.7 0.286 . . . . 8.5999999999999996 110.97 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.390000000000001 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.15 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 8.1999999999999993 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.8099999999999996 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.0999999999999996 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 5.7599999999999998 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.4699999999999998 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.1600000000000001 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 9.9499999999999993 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.2400000000000002 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.07 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.5099999999999998 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.539999999999999 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 8.6600000000000001 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.2199999999999998 111.087 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 6.8300000000000001 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7000000000000002 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.7699999999999996 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.1999999999999993 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.640000000000001 110.902 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.56 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 16.870000000000001 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.09 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.609999999999999 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.5700000000000003 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.8200000000000003 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.5 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.471 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 111.356 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.5300000000000002 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.5899999999999999 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.49 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.07 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.5800000000000001 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 9.3499999999999996 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.8099999999999996 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.8600000000000003 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.8600000000000003 110.867 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.9199999999999999 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 8.9499999999999993 111.069 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.26 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3000000000000007 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.4699999999999998 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 6.9199999999999999 110.691 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.0700000000000003 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.873 0.368 . . . . 8.5999999999999996 111.121 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.390000000000001 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.15 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 8.1999999999999993 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.8099999999999996 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.0999999999999996 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.551 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 5.7599999999999998 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.4699999999999998 111.197 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.1600000000000001 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 9.9499999999999993 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.2400000000000002 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.07 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.5099999999999998 111.403 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.539999999999999 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 8.6600000000000001 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.2199999999999998 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 6.8300000000000001 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 116' ' ' ILE . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7000000000000002 111.259 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.7699999999999996 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.1999999999999993 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 113' ' ' ILE . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.640000000000001 110.618 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.56 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 16.870000000000001 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.09 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.609999999999999 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.5700000000000003 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 135' ' ' GLU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.8200000000000003 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.5 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.1900000000000004 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 133' ' ' ARG . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.5300000000000002 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 130' ' ' TYR . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.5899999999999999 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.49 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.07 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.5800000000000001 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 9.3499999999999996 110.713 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.8099999999999996 111.16 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.8600000000000003 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.437 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.8600000000000003 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.9199999999999999 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 8.9499999999999993 110.976 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.26 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 6.9199999999999999 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.0700000000000003 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo . . . . . 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 18.9 m95 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.911 0.386 . . . . 8.5999999999999996 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.390000000000001 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.15 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 8.1999999999999993 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.488 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.8099999999999996 110.878 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.0999999999999996 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 5.7599999999999998 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.4699999999999998 111.328 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.1600000000000001 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 9.9499999999999993 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.2400000000000002 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.07 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.5099999999999998 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.539999999999999 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 8.6600000000000001 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.2199999999999998 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 6.8300000000000001 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 96' ' ' ASP . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7000000000000002 111.317 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.7699999999999996 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.423 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.1999999999999993 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 115' ' ' SER . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.640000000000001 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.56 110.173 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 16.870000000000001 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.09 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.609999999999999 110.974 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.5700000000000003 111.044 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.8200000000000003 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.5 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.773 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.1900000000000004 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.5300000000000002 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.5899999999999999 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.49 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.07 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.5800000000000001 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.541 ' HD2' HG13 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 9.3499999999999996 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.8099999999999996 111.007 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.8600000000000003 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.8600000000000003 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.9199999999999999 110.879 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 8.9499999999999993 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.26 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3000000000000007 111.08 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.4699999999999998 110.915 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 6.9199999999999999 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.0700000000000003 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo . . . . . 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.957 0.408 . . . . 8.5999999999999996 111.006 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.390000000000001 110.646 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.15 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 8.1999999999999993 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.77 ' HB3' HD12 ' A' ' 113' ' ' ILE . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.8099999999999996 111.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.0999999999999996 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 5.7599999999999998 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.4699999999999998 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.1600000000000001 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 9.9499999999999993 110.493 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.2400000000000002 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.07 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.5099999999999998 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.539999999999999 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 8.6600000000000001 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.2199999999999998 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 6.8300000000000001 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 96' ' ' ASP . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7000000000000002 111.412 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.7699999999999996 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.1999999999999993 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 113' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.640000000000001 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.56 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 16.870000000000001 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.09 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.609999999999999 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.5700000000000003 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.498 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.8200000000000003 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.5 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.5300000000000002 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.5899999999999999 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.49 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.07 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.5800000000000001 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 9.3499999999999996 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.8099999999999996 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.8600000000000003 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.8600000000000003 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.9199999999999999 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 8.9499999999999993 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.26 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3000000000000007 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.498 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.4699999999999998 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 6.9199999999999999 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.53 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.0700000000000003 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo . . . . . 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.903 0.382 . . . . 8.5999999999999996 111.198 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.390000000000001 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.15 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 8.1999999999999993 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.8099999999999996 110.762 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.0999999999999996 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 5.7599999999999998 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.1600000000000001 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 9.9499999999999993 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.2400000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.07 110.791 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.5099999999999998 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.539999999999999 110.548 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.483 ' HG2' ' OG1' ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 8.6600000000000001 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.2199999999999998 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 6.8300000000000001 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 116' ' ' ILE . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7000000000000002 111.518 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.7699999999999996 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.1999999999999993 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 138' ' ' LEU . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.640000000000001 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.56 110.627 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 16.870000000000001 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.09 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.609999999999999 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.5700000000000003 111.258 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.555 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.8200000000000003 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.5 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.1900000000000004 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 133' ' ' ARG . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.5300000000000002 110.501 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.5899999999999999 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.49 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.07 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.5800000000000001 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 126' ' ' VAL . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 9.3499999999999996 110.815 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.8600000000000003 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.8600000000000003 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.9199999999999999 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 8.9499999999999993 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.26 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3000000000000007 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.4699999999999998 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 6.9199999999999999 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.0700000000000003 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.861 0.362 . . . . 8.5999999999999996 110.931 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.390000000000001 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 94' ' ' VAL . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.15 110.994 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 8.1999999999999993 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.609 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.8099999999999996 110.98 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.0999999999999996 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 5.7599999999999998 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.4699999999999998 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.1600000000000001 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 9.9499999999999993 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.2400000000000002 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.07 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.5099999999999998 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.539999999999999 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 8.6600000000000001 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.2199999999999998 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 6.8300000000000001 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7000000000000002 111.534 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.7699999999999996 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.1999999999999993 110.876 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 113' ' ' ILE . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.640000000000001 111.376 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.56 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 16.870000000000001 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.09 110.835 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.609999999999999 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.5700000000000003 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.8200000000000003 110.927 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.5 110.542 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.1900000000000004 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.5300000000000002 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.5899999999999999 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.49 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.07 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.5800000000000001 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 9.3499999999999996 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.8099999999999996 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.8600000000000003 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.8600000000000003 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.9199999999999999 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 8.9499999999999993 111.176 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.26 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3000000000000007 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.419 HD11 ' SG ' ' A' ' 123' ' ' CYS . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.4699999999999998 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 6.9199999999999999 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.0700000000000003 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.587 0.232 . . . . 10.470000000000001 110.646 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 59.28 97.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.301 -0.409 . . . . 11.4 110.963 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -73.85 137.38 43.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 8.5999999999999996 111.08 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -143.41 171.12 14.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.148 -0.478 . . . . 12.390000000000001 110.76 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.7 t -65.74 134.01 30.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 10.15 111.021 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 78.31 72.57 1.15 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.773 -0.727 . . . . 8.1999999999999993 112.354 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.97 139.44 23.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.813 0.34 . . . . 6.8099999999999996 110.913 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.53 100.56 11.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.016 -0.538 . . . . 9.0999999999999996 110.815 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.9 p -118.01 -172.12 2.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 4.46 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.96 128.99 41.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 5.7599999999999998 110.756 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.46 143.28 50.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.955 0.407 . . . . 5.4699999999999998 111.456 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -84.69 144.22 10.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.888 -0.596 . . . . 8.1600000000000001 110.928 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -89.12 144.27 26.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.202 -0.454 . . . . 9.9499999999999993 111.034 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -94.38 20.63 8.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.043 -0.526 . . . . 9.2400000000000002 110.867 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -108.84 -39.16 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.276 -0.42 . . . . 11.5 110.999 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -129.73 -11.25 4.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 12.93 110.87 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.62 62.54 4.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.691 -0.766 . . . . 11.27 112.409 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.7 m -140.5 161.65 37.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.817 0.341 . . . . 12.07 110.841 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.3 128.46 39.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.416 . . . . 9.5099999999999998 111.144 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -141.03 143.93 33.16 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.242 -0.436 . . . . 11.539999999999999 110.78 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -50.28 143.69 25.6 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.679 2.253 . . . . 8.6600000000000001 112.407 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.461 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -145.73 168.35 20.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 5.2199999999999998 111.398 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.2 m -144.82 116.01 7.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.031 -0.532 . . . . 6.8300000000000001 111.045 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mt -62.57 107.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.459 . . . . 6.7000000000000002 111.008 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.8 -37.53 14.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.085 -0.507 . . . . 8.7699999999999996 112.367 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.43 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.5 OUTLIER -148.62 155.81 41.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.887 0.375 . . . . 9.1999999999999993 110.943 -179.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.43 HG13 ' C ' ' A' ' 115' ' ' SER . 3.4 mt -141.12 146.14 24.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 10.640000000000001 111.359 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.92 91.17 3.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.086 -0.506 . . . . 11.56 110.611 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -54.86 -21.96 13.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 14.24 111.714 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.473 ' H ' ' HG2' ' A' ' 119' ' ' LYS . 0.0 OUTLIER -53.94 -66.95 0.3 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.802 0.334 . . . . 16.870000000000001 111.077 -179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -96.21 23.57 6.47 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.209 -0.45 . . . . 15.09 111.083 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 43.44 60.89 2.42 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.015 -0.539 . . . . 13.609999999999999 111.341 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.3 p -137.93 -178.47 5.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.313 -0.403 . . . . 9.5700000000000003 111.013 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 12.6 p -165.97 170.86 13.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 6.8200000000000003 111.088 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.88 127.41 75.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 6.5 110.553 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 12.5 m -110.79 142.78 22.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.932 0.396 . . . . 4.1900000000000004 111.619 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.694 HG22 ' HG2' ' A' ' 133' ' ' ARG . 14.8 t -105.27 129.29 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.781 -0.645 . . . . 7.5300000000000002 110.448 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 8.6 m-85 -79.43 105.02 10.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.906 0.384 . . . . 8.5899999999999999 111.086 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.48 106.23 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.825 -0.625 . . . . 10.27 111.428 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.29 -24.9 19.58 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.73 -0.748 . . . . 12.41 112.849 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.436 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 89.9 m-85 -100.73 -29.08 12.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.817 0.341 . . . . 11.49 110.959 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 83.28 -33.55 2.94 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.851 -0.69 . . . . 10.07 112.914 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -53.31 143.67 18.16 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 8.5800000000000001 111.471 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.694 ' HG2' HG22 ' A' ' 126' ' ' VAL . 24.2 mtp180 -124.99 125.48 43.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.063 -0.517 . . . . 9.3499999999999996 110.352 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.4 143.82 51.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.837 0.351 . . . . 5.8099999999999996 111.276 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -81.16 130.59 35.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 7.8600000000000003 110.775 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.11 175.27 9.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 5.8600000000000003 110.907 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.596 HD21 ' HB3' ' A' ' 139' ' ' SER . 37.9 t30 -94.35 136.91 34.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.289 -0.414 . . . . 8.9199999999999999 110.72 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 mt -57.6 -37.83 73.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.318 -0.401 . . . . 8.9499999999999993 111.267 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 137' ' ' ASN . 0.4 OUTLIER -69.08 -12.47 61.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.366 -0.379 . . . . 10.26 110.895 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -104.87 8.27 34.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 8.3000000000000007 111.228 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 141' ' ' LEU . 17.3 mt -78.9 125.46 29.4 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.199 -0.455 . . . . 5.4699999999999998 110.914 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.5 mt -92.06 152.16 20.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.272 -0.422 . . . . 6.9199999999999999 110.939 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.23 157.13 88.66 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 6.0700000000000003 110.928 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.57 -179.61 0.98 Allowed 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.52 2.147 . . . . 7.04 112.431 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.192 -0.458 . . . . 9.9399999999999995 111.112 -179.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.886 0.374 . . . . 10.470000000000001 110.952 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.6 -130.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.083 -0.508 . . . . 11.4 110.751 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -144.23 123.6 13.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.311 -0.404 . . . . 8.5999999999999996 110.711 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.2 mtpm? -138.79 164.48 29.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 12.390000000000001 110.725 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.03 132.03 27.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.228 -0.442 . . . . 10.15 110.824 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.39 74.44 1.18 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.907 -0.663 . . . . 8.1999999999999993 111.966 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.679 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.1 t70 -153.48 126.06 8.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 6.8099999999999996 110.841 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.432 ' O ' ' HB3' ' A' ' 144' ' ' PRO . 3.6 mttp -68.47 108.68 3.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 9.0999999999999996 110.678 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 19.6 p -125.75 -164.74 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 4.46 111.007 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.432 ' HB3' ' HB2' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -131.95 127.53 36.55 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.192 -0.458 . . . . 5.7599999999999998 110.699 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.47 50.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.348 -0.387 . . . . 5.4699999999999998 111.209 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.97 139.14 17.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.504 . . . . 8.1600000000000001 111.293 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.432 ' HA ' ' HH ' ' A' ' 127' ' ' TYR . 3.3 t90 -86.5 136.11 33.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 9.9499999999999993 110.84 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.82 29.09 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 9.2400000000000002 111.158 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.95 -49.71 3.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.209 -0.451 . . . . 11.5 110.817 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -129.85 -2.88 4.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.504 . . . . 12.93 110.829 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.4 37.34 47.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 11.27 112.337 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -107.33 151.85 24.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.838 0.352 . . . . 12.07 110.805 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.48 129.76 37.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 9.5099999999999998 111.118 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -137.65 148.81 62.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 11.539999999999999 110.864 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.39 143.73 97.25 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.495 2.13 . . . . 8.6600000000000001 112.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.771 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.18 166.27 25.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 5.2199999999999998 111.529 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -137.84 117.41 12.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 6.8300000000000001 110.828 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.4 mt -60.26 108.71 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 6.7000000000000002 111.648 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.69 -33.6 15.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 8.7699999999999996 111.659 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.41 ' C ' HG13 ' A' ' 116' ' ' ILE . 0.3 OUTLIER -160.92 153.67 20.93 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.691 0.281 . . . . 9.1999999999999993 110.822 -179.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.598 HD11 HG21 ' A' ' 113' ' ' ILE . 7.0 mt -137.2 150.59 26.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 10.640000000000001 111.222 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -134.61 93.68 3.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.188 -0.46 . . . . 11.56 110.712 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.49 -9.02 0.95 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.065 -0.516 . . . . 14.24 111.887 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.74 -72.52 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.699 0.285 . . . . 16.870000000000001 110.934 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -109.73 37.29 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 15.09 110.78 179.823 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 45.56 64.92 1.26 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.886 -0.597 . . . . 13.609999999999999 111.087 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 42.6 p -131.52 168.63 17.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.317 -0.401 . . . . 9.5700000000000003 111.091 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 1.2 p -162.43 167.46 23.57 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 6.8200000000000003 111.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.19 118.62 53.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.048 -0.524 . . . . 6.5 110.546 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.771 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 7.0 m -109.86 138.96 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.366 -0.379 . . . . 4.1900000000000004 111.409 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 3.7 t -100.16 137.17 28.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.013 -0.539 . . . . 7.5300000000000002 110.673 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.599 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 7.0 m-85 -81.21 102.43 10.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.954 0.407 . . . . 8.5899999999999999 110.922 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 119.12 5.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.931 -0.577 . . . . 10.27 111.709 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 84.06 12.26 77.04 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.772 -0.728 . . . . 12.41 113.258 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.599 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 14.6 m-85 -127.36 -22.98 3.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.859 0.33 . . . . 11.49 111.114 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 62.11 44.77 97.3 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.932 -0.652 . . . . 10.07 112.909 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.16 147.37 45.88 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.69 0.281 . . . . 8.5800000000000001 110.826 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 133' ' ' ARG . 8.7 mtm180 -112.51 135.99 52.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.776 0.322 . . . . 9.3499999999999996 110.883 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.68 120.52 16.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 5.8099999999999996 110.717 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -72.0 126.93 31.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.879 0.371 . . . . 7.8600000000000003 111.119 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.33 171.48 13.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.077 -0.51 . . . . 5.8600000000000003 110.785 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.425 HD22 ' N ' ' A' ' 137' ' ' ASN . 1.6 m-80 -99.29 143.3 29.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.441 . . . . 8.9199999999999999 110.876 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.4 mt -57.09 -39.88 75.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 8.9499999999999993 111.109 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 11.5 t -69.65 -14.43 62.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.297 -0.41 . . . . 10.26 110.942 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.28 5.1 31.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 8.3000000000000007 111.215 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 47.6 mt -76.68 140.54 40.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.359 -0.382 . . . . 5.4699999999999998 110.804 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 3.0 mt -110.44 153.96 24.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.411 . . . . 6.9199999999999999 110.883 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.436 ' O ' HG12 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -74.82 158.07 85.06 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.148 -0.478 . . . . 6.0700000000000003 110.77 179.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.432 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 41.7 Cg_endo -66.99 93.37 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.449 2.099 . . . . 7.04 112.128 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.436 HG12 ' O ' ' A' ' 143' ' ' SER . 16.5 mm . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 9.9399999999999995 111.091 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.716 0.293 . . . . 10.470000000000001 110.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -172.17 153.45 3.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 11.4 110.745 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 28.5 m95 -83.36 122.79 28.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.996 0.427 . . . . 8.5999999999999996 110.899 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -149.06 171.85 15.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.931 -0.577 . . . . 12.390000000000001 110.571 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.94 130.65 26.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.808 0.337 . . . . 10.15 110.917 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 80.2 70.99 1.3 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.924 -0.655 . . . . 8.1999999999999993 112.101 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' HB2' HD12 ' A' ' 113' ' ' ILE . 10.0 m-20 -153.27 121.32 6.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.797 0.332 . . . . 6.8099999999999996 110.816 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.17 104.97 0.99 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.239 -0.437 . . . . 9.0999999999999996 111.056 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.419 ' SG ' HG13 ' A' ' 113' ' ' ILE . 28.5 p -120.69 -170.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.23 -0.441 . . . . 4.46 110.907 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.81 141.43 40.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 5.7599999999999998 110.565 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -139.31 149.55 44.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.385 -0.37 . . . . 5.4699999999999998 111.339 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 10.6 mt -81.89 139.57 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.085 -0.507 . . . . 8.1600000000000001 111.101 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -93.67 154.17 17.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.059 -0.519 . . . . 9.9499999999999993 110.814 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 p -101.52 13.68 34.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 9.2400000000000002 110.766 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -35.4 11.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 11.5 110.844 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -138.86 -7.49 1.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 12.93 110.939 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 68.96 62.41 4.02 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.798 -0.715 . . . . 11.27 112.662 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.52 163.57 34.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.776 0.322 . . . . 12.07 110.715 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 51.2 mt -89.05 133.34 31.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.301 -0.408 . . . . 9.5099999999999998 110.914 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -139.03 153.63 71.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 11.539999999999999 110.957 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -57.38 143.38 94.15 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.55 2.166 . . . . 8.6600000000000001 112.267 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.781 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.11 168.91 22.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.485 . . . . 5.2199999999999998 111.145 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.6 m -137.14 121.7 18.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 6.8300000000000001 111.09 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.643 HG21 HD11 ' A' ' 116' ' ' ILE . 21.7 mt -64.73 104.61 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.011 -0.54 . . . . 6.7000000000000002 111.16 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.06 -39.25 13.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 8.7699999999999996 111.592 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 24.5 p -151.44 146.95 26.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 9.1999999999999993 110.754 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.643 HD11 HG21 ' A' ' 113' ' ' ILE . 72.7 mt -132.48 145.45 34.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 10.640000000000001 111.192 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -127.71 136.08 51.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 11.56 109.979 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 17.8 m-30 -100.23 4.73 44.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.402 -0.363 . . . . 14.24 111.122 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -68.8 -72.15 0.19 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 16.870000000000001 110.534 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 7.7 mtm180 -103.49 24.48 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.153 -0.476 . . . . 15.09 110.722 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 50.67 69.95 0.58 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.885 -0.598 . . . . 13.609999999999999 111.17 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.7 p -140.29 176.33 8.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 9.5700000000000003 111.242 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.36 169.32 19.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 6.8200000000000003 110.991 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 75.0 t -124.93 114.26 39.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 6.5 111.042 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.781 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 26.4 m -105.16 144.86 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 4.1900000000000004 111.273 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 133' ' ' ARG . 14.8 t -108.38 125.96 65.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 7.5300000000000002 110.207 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 134' ' ' GLU . 27.0 m-85 -72.08 112.61 8.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.094 0.473 . . . . 8.5899999999999999 111.125 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 98.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 10.27 111.685 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 115.21 -6.79 21.29 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.689 -0.767 . . . . 12.41 113.236 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.472 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 85.9 m-85 -111.18 -23.99 10.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.891 0.346 . . . . 11.49 111.184 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.32 33.71 87.98 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.679 -0.772 . . . . 10.07 112.625 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 32.8 t30 -125.32 153.6 43.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.598 0.237 . . . . 8.5800000000000001 110.573 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 126' ' ' VAL . 6.2 mpt_? -118.41 126.14 51.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.889 0.376 . . . . 9.3499999999999996 111.236 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 127' ' ' TYR . 0.8 OUTLIER -127.4 132.21 50.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.053 -0.521 . . . . 5.8099999999999996 110.553 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -78.16 128.69 34.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.331 -0.395 . . . . 7.8600000000000003 111.23 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.427 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 2.5 tp60 -131.34 168.33 17.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.032 -0.531 . . . . 5.8600000000000003 110.696 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.8 m120 -91.29 133.17 35.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.311 -0.404 . . . . 8.9199999999999999 111.19 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -56.21 -46.86 79.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.979 -0.555 . . . . 8.9499999999999993 111.169 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.47 -14.41 62.19 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.218 -0.446 . . . . 10.26 110.905 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.496 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.1 OUTLIER -104.48 2.74 31.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 8.3000000000000007 110.997 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 16.9 mt -67.67 146.81 53.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.33 -0.395 . . . . 5.4699999999999998 110.778 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -114.18 147.1 39.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 6.9199999999999999 111.02 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.22 158.33 86.95 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 6.0700000000000003 110.762 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -56.72 -79.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.679 2.253 . . . . 7.04 112.504 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 pt . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 120.888 0.375 . . . . 9.9399999999999995 111.212 -179.859 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.689 0.28 . . . . 10.470000000000001 110.805 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -83.5 113.18 20.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 11.4 111.037 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -78.92 135.53 37.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 8.5999999999999996 110.931 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? -137.28 168.47 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.164 -0.471 . . . . 12.390000000000001 110.913 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 2.8 t -65.75 120.35 12.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 10.15 110.769 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 87.6 78.7 1.26 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.842 -0.694 . . . . 8.1999999999999993 112.369 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -154.23 127.26 8.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.796 0.331 . . . . 6.8099999999999996 110.676 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.477 ' NZ ' HG21 ' A' ' 128' ' ' THR . 0.4 OUTLIER -71.0 111.83 6.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 9.0999999999999996 111.112 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.2 p -129.09 -162.54 1.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.032 -0.531 . . . . 4.46 110.769 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 14.8 m -138.7 141.21 38.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.319 -0.4 . . . . 5.7599999999999998 110.998 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.52 149.95 41.53 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 5.4699999999999998 111.13 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.22 142.45 13.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 8.1600000000000001 111.011 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . 0.43 ' HA ' ' OH ' ' A' ' 127' ' ' TYR . 3.5 t90 -90.11 135.3 33.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 9.9499999999999993 111.014 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.85 18.15 6.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.058 -0.519 . . . . 9.2400000000000002 110.765 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -115.86 -42.55 3.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.504 . . . . 11.5 111.011 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.33 -22.92 10.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.231 -0.441 . . . . 12.93 110.89 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.06 47.21 8.59 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.789 -0.719 . . . . 11.27 112.623 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -141.99 160.09 40.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 12.07 110.835 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.1 mt -79.8 133.03 30.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.194 -0.457 . . . . 9.5099999999999998 111.068 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -139.96 153.58 69.69 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 11.539999999999999 110.838 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.95 131.34 43.07 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.495 2.13 . . . . 8.6600000000000001 112.248 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' VAL . . . -136.44 163.64 30.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 5.2199999999999998 110.944 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.6 m -137.63 130.22 29.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.318 -0.401 . . . . 6.8300000000000001 111.317 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.663 HG21 HD11 ' A' ' 116' ' ' ILE . 2.4 mp -71.15 111.79 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 6.7000000000000002 111.264 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -94.65 -41.1 9.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.02 -0.536 . . . . 8.7699999999999996 111.62 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 2.5 p -146.64 144.99 29.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.715 0.293 . . . . 9.1999999999999993 111.099 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.663 HD11 HG21 ' A' ' 113' ' ' ILE . 77.0 mt -133.21 145.01 34.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 10.640000000000001 111.192 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -129.73 132.67 46.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.974 -0.557 . . . . 11.56 110.103 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -99.85 12.03 37.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.256 -0.429 . . . . 14.24 111.102 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.8 -58.17 2.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.061 -0.518 . . . . 16.870000000000001 110.691 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.54 22.68 14.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.517 . . . . 15.09 110.66 179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 47.51 68.09 0.71 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.844 -0.616 . . . . 13.609999999999999 111.087 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 21.5 p -133.27 165.42 24.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.406 -0.361 . . . . 9.5700000000000003 111.315 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.487 ' SG ' HD11 ' A' ' 141' ' ' LEU . 21.0 p -165.93 135.51 3.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.304 -0.407 . . . . 6.8200000000000003 111.148 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.1 t -94.04 132.14 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 6.5 110.749 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.418 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 18.8 m -117.03 148.33 19.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 4.1900000000000004 111.455 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 14.6 t -107.79 135.23 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.908 -0.587 . . . . 7.5300000000000002 110.515 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.746 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 13.5 m-85 -85.23 95.41 9.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 8.5899999999999999 111.006 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.477 HG21 ' NZ ' ' A' ' 97' ' ' LYS . 0.2 OUTLIER -54.81 118.01 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.516 -179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 85.45 16.49 64.13 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.866 -0.683 . . . . 12.41 112.878 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.746 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 16.8 m-85 -133.62 -22.3 1.92 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.764 0.316 . . . . 11.49 111.096 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 60.19 43.31 98.55 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.88 -0.676 . . . . 10.07 112.546 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -136.13 144.06 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.675 0.274 . . . . 8.5800000000000001 110.369 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -118.66 138.36 52.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.772 0.32 . . . . 9.3499999999999996 111.288 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.8 138.67 34.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 5.8099999999999996 110.834 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -86.41 125.28 33.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.951 0.405 . . . . 7.8600000000000003 110.856 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 29.1 mm100 -130.76 173.92 10.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.975 -0.557 . . . . 5.8600000000000003 110.621 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -104.81 151.48 23.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 8.9199999999999999 110.849 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mt -57.49 -33.12 67.68 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.206 -0.452 . . . . 8.9499999999999993 111.377 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 92.4 p -68.7 -11.86 60.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 10.26 111.363 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.48 13.83 21.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.498 -0.319 . . . . 8.3000000000000007 111.468 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.487 HD11 ' SG ' ' A' ' 123' ' ' CYS . 70.9 mt -90.05 132.18 35.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.865 0.364 . . . . 5.4699999999999998 110.996 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 4.5 mt -108.07 154.77 21.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.153 -0.476 . . . . 6.9199999999999999 111.034 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.46 154.22 87.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 6.0700000000000003 110.839 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.28 176.91 2.9 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.627 2.218 . . . . 7.04 112.545 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 11.4 mm . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.958 -0.564 . . . . 9.9399999999999995 111.549 179.89 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.552 0.215 . . . . 10.470000000000001 110.648 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 65.08 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.13 -0.486 . . . . 11.4 110.897 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 41.5 m95 -144.67 124.34 13.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.216 -0.447 . . . . 8.5999999999999996 110.97 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.73 166.72 22.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 12.390000000000001 110.791 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 4.9 t -61.3 111.97 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.318 -0.401 . . . . 10.15 110.882 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.51 82.81 1.66 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.791 -0.718 . . . . 8.1999999999999993 112.283 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -158.88 139.34 12.44 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.884 0.373 . . . . 6.8099999999999996 110.949 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.7 116.84 24.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.01 -0.541 . . . . 9.0999999999999996 110.776 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 32.0 p -136.43 -155.91 0.66 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 4.46 110.709 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -137.74 138.08 38.94 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.344 -0.389 . . . . 5.7599999999999998 110.571 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.88 154.09 51.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 5.4699999999999998 111.391 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.1 mt -89.88 132.86 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.029 -0.532 . . . . 8.1600000000000001 110.923 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -90.2 122.62 33.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.321 -0.399 . . . . 9.9499999999999993 110.961 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.8 p -76.06 -12.7 60.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.898 -0.592 . . . . 9.2400000000000002 111.029 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -73.3 -37.58 66.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 11.5 110.888 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -117.23 -76.97 0.57 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 12.93 110.811 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 142.12 43.24 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.894 -0.669 . . . . 11.27 112.332 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.14 167.41 22.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.913 0.387 . . . . 12.07 111.21 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.1 mt -90.69 130.18 40.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.946 -0.57 . . . . 9.5099999999999998 110.959 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -136.12 155.0 77.8 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 11.539999999999999 110.797 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.29 138.62 87.05 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.383 2.055 . . . . 8.6600000000000001 112.288 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -144.34 163.25 34.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.146 -0.479 . . . . 5.2199999999999998 111.087 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 m -135.22 114.46 12.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 6.8300000000000001 110.833 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 2.0 mp -61.68 105.93 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.321 -0.4 . . . . 6.7000000000000002 111.24 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.53 -33.33 16.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 8.7699999999999996 111.834 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.77 149.25 34.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 9.1999999999999993 111.196 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 79.6 mt -135.4 145.2 32.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.909 -0.587 . . . . 10.640000000000001 110.902 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -132.82 97.12 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.098 -0.501 . . . . 11.56 110.749 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -70.79 14.7 0.13 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.935 -0.575 . . . . 14.24 111.781 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' C ' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -99.93 -60.62 1.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 16.870000000000001 110.677 179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.44 27.99 3.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.204 -0.453 . . . . 15.09 110.491 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 38.87 56.31 1.97 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.72 -0.673 . . . . 13.609999999999999 111.495 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.8 p -139.01 168.4 19.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 9.5700000000000003 111.345 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.45 ' SG ' HD11 ' A' ' 141' ' ' LEU . 11.7 p -165.96 140.14 4.48 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 6.8200000000000003 110.984 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 83.9 t -90.05 142.42 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.07 -0.514 . . . . 6.5 110.808 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.471 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 14.2 m -129.06 151.62 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.008 0.432 . . . . 4.1900000000000004 111.356 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 133' ' ' ARG . 40.6 t -114.22 133.87 58.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.913 -0.585 . . . . 7.5300000000000002 110.616 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 130' ' ' TYR . 11.0 m-85 -80.75 108.86 14.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.114 0.483 . . . . 8.5899999999999999 111.12 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.02 -67.54 0.28 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.553 -0.748 . . . . 10.27 111.959 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.35 -7.84 11.11 Favored Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.106 -0.569 . . . . 12.41 113.567 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HB2' ' HB3' ' A' ' 127' ' ' TYR . 34.3 m-85 -115.28 -95.08 0.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.172 0.486 . . . . 11.49 111.243 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 149.52 6.82 0.19 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.996 -0.621 . . . . 10.07 111.898 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -89.83 156.33 18.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 8.5800000000000001 110.756 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 126' ' ' VAL . 1.2 ttm180 -127.51 116.38 20.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.507 -0.315 . . . . 9.3499999999999996 110.365 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -131.94 158.77 40.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.433 -0.349 . . . . 5.8099999999999996 111.25 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -90.55 138.05 31.87 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 7.8600000000000003 110.922 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.435 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 0.0 OUTLIER -138.44 173.13 11.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 5.8600000000000003 110.867 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.435 ' H ' ' HG3' ' A' ' 136' ' ' GLN . 0.2 OUTLIER -96.67 136.48 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.419 . . . . 8.9199999999999999 110.904 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.96 -37.29 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.06 -0.518 . . . . 8.9499999999999993 111.069 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 -14.56 63.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 10.26 110.976 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.53 7.13 37.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.429 . . . . 8.3000000000000007 110.823 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' ' 123' ' ' CYS . 56.4 mt -78.43 141.39 38.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.156 -0.475 . . . . 5.4699999999999998 110.991 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 5.2 mt -109.09 152.19 25.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.094 -0.503 . . . . 6.9199999999999999 110.691 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.07 149.68 73.62 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 6.0700000000000003 111.158 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.22 136.26 19.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.653 2.235 . . . . 7.04 112.263 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.299 -0.409 . . . . 9.9399999999999995 111.115 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.693 0.282 . . . . 10.470000000000001 111.106 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.589 HE21 ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -59.02 161.08 5.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 11.4 110.956 -179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 23.9 m95 -132.72 114.5 14.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.32 -0.4 . . . . 8.5999999999999996 111.121 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HG2' ' H ' ' A' ' 94' ' ' VAL . 18.3 ttpt -139.15 163.79 31.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 12.390000000000001 110.606 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' H ' ' HG2' ' A' ' 93' ' ' LYS . 2.9 t -58.44 110.91 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.932 0.396 . . . . 10.15 110.83 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.36 77.34 1.32 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.951 -0.643 . . . . 8.1999999999999993 111.939 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -154.16 127.01 8.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.774 0.321 . . . . 6.8099999999999996 110.689 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.26 111.22 7.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.268 -0.424 . . . . 9.0999999999999996 111.024 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.551 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . 21.0 p -136.26 -154.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.968 -0.56 . . . . 4.46 110.72 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 150.98 42.17 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.332 -0.395 . . . . 5.7599999999999998 110.645 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.427 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -139.49 156.33 46.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.466 -0.334 . . . . 5.4699999999999998 111.197 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 mt -93.83 132.22 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.058 -0.519 . . . . 8.1600000000000001 111.355 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -90.21 146.84 23.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.504 . . . . 9.9499999999999993 110.677 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.36 36.54 1.46 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.319 -0.401 . . . . 9.2400000000000002 111.019 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -110.18 -35.36 6.12 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 11.5 110.867 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -149.29 0.3 0.51 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.268 -0.424 . . . . 12.93 110.813 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 74.83 40.52 36.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 11.27 112.602 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 89.5 m -116.03 155.11 28.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.811 0.339 . . . . 12.07 110.733 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.3 mt -96.75 133.76 36.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.222 -0.445 . . . . 9.5099999999999998 111.403 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -135.23 151.47 75.13 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.949 -0.569 . . . . 11.539999999999999 110.652 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.46 137.69 78.28 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.557 2.171 . . . . 8.6600000000000001 112.058 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -149.42 171.42 16.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 5.2199999999999998 111.396 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.32 141.44 37.69 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.983 -0.553 . . . . 6.8300000000000001 110.93 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 116' ' ' ILE . 2.7 mp -76.39 105.75 5.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 6.7000000000000002 111.259 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.77 -32.81 16.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 8.7699999999999996 111.744 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 66.9 m -152.85 156.53 39.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.988 0.423 . . . . 9.1999999999999993 111.081 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.469 HD11 HG21 ' A' ' 113' ' ' ILE . 34.2 mt -139.84 147.98 23.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.87 -0.605 . . . . 10.640000000000001 110.618 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.97 95.04 3.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.268 -0.424 . . . . 11.56 110.924 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -56.25 -10.48 0.89 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.057 -0.519 . . . . 14.24 111.67 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.97 -75.4 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 16.870000000000001 111.074 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 120' ' ' ARG . 3.2 mtp85 -106.28 33.99 3.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 15.09 110.741 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 45.78 65.02 1.25 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.827 -0.624 . . . . 13.609999999999999 111.017 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 22.0 p -136.87 178.56 6.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.35 -0.386 . . . . 9.5700000000000003 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 135' ' ' GLU . 25.7 p -167.94 171.33 9.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 6.8200000000000003 111.07 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 94.7 t -122.76 123.6 68.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.974 -0.557 . . . . 6.5 110.694 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 15.7 m -113.59 142.22 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.933 0.397 . . . . 4.1900000000000004 111.568 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' A' ' 133' ' ' ARG . 48.8 t -102.77 139.2 24.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.515 . . . . 7.5300000000000002 110.836 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.431 ' HB3' ' CD2' ' A' ' 130' ' ' TYR . 8.6 m-85 -80.4 100.55 8.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.35 -0.387 . . . . 8.5899999999999999 111.159 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 107.64 0.77 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.966 -0.561 . . . . 10.27 111.431 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 106.96 -2.76 35.59 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.636 -0.793 . . . . 12.41 113.02 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 127' ' ' TYR . 85.6 m-85 -120.64 -21.25 6.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.856 0.328 . . . . 11.49 111.229 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 64.09 41.72 98.37 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.732 -0.747 . . . . 10.07 112.592 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -130.82 151.62 51.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.625 0.25 . . . . 8.5800000000000001 110.771 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.437 ' HG3' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -111.96 139.87 47.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.517 -0.311 . . . . 9.3499999999999996 110.713 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -147.0 130.87 17.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.413 . . . . 5.8099999999999996 111.16 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 123' ' ' CYS . 2.8 tm-20 -83.43 135.08 34.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 7.8600000000000003 110.881 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.437 ' HG3' ' H ' ' A' ' 137' ' ' ASN . 1.1 tp60 -142.33 177.56 8.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.286 -0.415 . . . . 5.8600000000000003 110.952 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.482 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 37.4 m-20 -100.38 141.34 33.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 8.9199999999999999 110.922 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 22.0 mt -57.94 -46.05 85.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 8.9499999999999993 110.976 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -15.33 63.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.132 -0.485 . . . . 10.26 110.848 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.482 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.3 OUTLIER -96.82 -14.81 21.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.069 -0.514 . . . . 8.3000000000000007 111.01 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.453 HD21 HG11 ' A' ' 125' ' ' VAL . 28.1 mt -63.85 147.7 51.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 5.4699999999999998 111.072 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 9.5 mt -118.72 174.06 6.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 6.9199999999999999 110.786 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.64 154.99 56.5 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 6.0700000000000003 110.943 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.551 ' HD3' ' HA ' ' A' ' 98' ' ' CYS . 27.5 Cg_endo -61.64 125.52 16.91 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.698 2.265 . . . . 7.04 112.187 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.4 mm . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 9.9399999999999995 111.004 -179.983 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.912 0.387 . . . . 10.470000000000001 111.252 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.93 143.89 30.28 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.028 -0.533 . . . . 11.4 111.181 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -71.02 85.39 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.082 -0.508 . . . . 8.5999999999999996 111.124 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.28 159.18 15.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 12.390000000000001 110.752 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.2 t -56.43 142.56 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.821 0.343 . . . . 10.15 110.802 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.78 68.82 1.5 Allowed Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.641 -0.79 . . . . 8.1999999999999993 111.799 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.488 ' HB3' HD12 ' A' ' 113' ' ' ILE . 1.7 t70 -150.06 129.15 12.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 6.8099999999999996 110.878 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 mmtp -80.2 108.57 13.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.516 . . . . 9.0999999999999996 110.756 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 29.9 p -126.09 -165.13 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 4.46 111.048 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -127.47 120.46 28.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.428 . . . . 5.7599999999999998 110.777 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' CB ' HG21 ' A' ' 125' ' ' VAL . . . -112.72 139.68 48.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 5.4699999999999998 111.328 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.61 137.12 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 8.1600000000000001 110.822 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -85.35 134.93 34.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 9.9499999999999993 110.844 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.21 28.07 0.54 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 9.2400000000000002 110.943 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.41 -39.55 5.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 11.5 110.798 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -144.88 -1.88 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 12.93 110.87 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 72.14 44.89 42.97 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.878 -0.677 . . . . 11.27 112.567 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 61.5 m -107.58 158.29 17.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.854 0.359 . . . . 12.07 110.89 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -89.98 123.21 42.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.515 . . . . 9.5099999999999998 111.177 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -134.13 152.05 77.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 11.539999999999999 110.984 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.43 138.73 78.18 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.58 2.187 . . . . 8.6600000000000001 111.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.773 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -143.66 164.98 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 5.2199999999999998 111.444 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.2 m -142.41 112.85 7.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.036 -0.529 . . . . 6.8300000000000001 110.944 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.488 HD12 ' HB3' ' A' ' 96' ' ' ASP . 3.7 mt -58.55 104.97 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.313 -0.403 . . . . 6.7000000000000002 111.317 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.57 -34.24 16.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.525 . . . . 8.7699999999999996 111.786 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.423 ' C ' HG13 ' A' ' 116' ' ' ILE . 11.8 m -151.23 156.23 40.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.677 0.275 . . . . 9.1999999999999993 110.687 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 115' ' ' SER . 12.3 mt -139.88 147.32 23.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.001 0.429 . . . . 10.640000000000001 111.545 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -124.84 134.68 52.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.804 -0.635 . . . . 11.56 110.173 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -99.9 9.38 43.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 14.24 111.389 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.5 tptp -81.79 -73.98 0.36 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.456 -0.338 . . . . 16.870000000000001 110.646 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -91.03 20.28 5.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.221 -0.445 . . . . 15.09 110.705 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 49.72 68.11 0.79 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.884 -0.598 . . . . 13.609999999999999 110.974 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.6 p -146.86 -175.34 4.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.467 . . . . 9.5700000000000003 111.044 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 135' ' ' GLU . 9.0 p -167.27 178.67 5.45 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.349 -0.387 . . . . 6.8200000000000003 111.208 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 98.7 t -125.74 138.37 54.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 6.5 110.962 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.773 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 29.2 m -128.14 138.15 55.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 4.1900000000000004 111.187 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG13 ' HD2' ' A' ' 133' ' ' ARG . 3.4 t -96.25 129.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 7.5300000000000002 110.872 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -75.09 101.67 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.105 -0.498 . . . . 8.5899999999999999 111.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.93 139.11 58.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 10.27 111.237 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 79.6 -0.86 80.05 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.848 -0.691 . . . . 12.41 112.865 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -114.72 -94.12 0.48 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.533 0.206 . . . . 11.49 111.036 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 145.39 17.98 0.17 Allowed Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.722 -0.752 . . . . 10.07 112.15 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -119.75 157.33 28.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.766 0.317 . . . . 8.5800000000000001 110.882 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.541 ' HD2' HG13 ' A' ' 126' ' ' VAL . 3.3 mpt_? -119.62 124.06 45.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 9.3499999999999996 110.682 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -123.73 127.59 48.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 5.8099999999999996 111.007 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 123' ' ' CYS . 14.7 tt0 -79.25 131.3 36.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 7.8600000000000003 110.714 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 2.5 tp60 -131.44 173.36 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 5.8600000000000003 110.957 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 10.2 m120 -96.92 142.79 28.47 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 8.9199999999999999 110.879 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 10.2 mt -55.25 -45.19 76.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 8.9499999999999993 111.167 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -15.56 63.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.296 -0.411 . . . . 10.26 111.25 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 137' ' ' ASN . 0.5 OUTLIER -101.59 10.48 40.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.282 -0.417 . . . . 8.3000000000000007 111.08 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.0 mt -85.29 143.85 28.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.419 . . . . 5.4699999999999998 110.915 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.433 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 27.7 mt -116.78 165.65 13.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.209 -0.45 . . . . 6.9199999999999999 110.999 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.8 p -86.87 154.36 55.44 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.076 -0.511 . . . . 6.0700000000000003 110.679 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.92 -35.61 65.76 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.42 2.08 . . . . 7.04 112.32 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 tt . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.144 -0.48 . . . . 9.9399999999999995 110.986 -179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.082 0 CA-C-O 120.574 0.226 . . . . 10.470000000000001 110.456 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 65.68 133.03 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.124 -0.489 . . . . 11.4 110.764 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -77.51 116.71 18.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 8.5999999999999996 111.006 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.83 167.16 22.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.951 -0.568 . . . . 12.390000000000001 110.646 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 14.6 t -59.95 117.76 2.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.036 0.446 . . . . 10.15 111.198 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.47 76.1 1.27 Allowed Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.701 -0.681 . . . . 8.1999999999999993 112.405 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.77 ' HB3' HD12 ' A' ' 113' ' ' ILE . 34.5 t0 -157.13 121.46 4.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 6.8099999999999996 111.03 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 mmtp -66.74 103.3 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 9.0999999999999996 110.621 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 25.4 p -124.99 -161.43 1.02 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 4.46 111.039 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.611 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 4.4 m -139.47 141.41 37.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 5.7599999999999998 110.746 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.04 154.44 49.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 5.4699999999999998 111.141 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -95.76 135.22 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.112 -0.494 . . . . 8.1600000000000001 110.986 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.8 t90 -86.08 131.99 34.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 9.9499999999999993 110.493 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 21.5 m -88.64 14.37 10.18 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.195 -0.457 . . . . 9.2400000000000002 111.479 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -97.23 -30.21 13.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 11.5 110.62 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -126.94 -70.74 0.71 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.891 -0.595 . . . . 12.93 110.358 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 137.59 54.4 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.793 -0.717 . . . . 11.27 112.466 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -145.69 165.82 27.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 12.07 111.052 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.9 mt -100.87 130.43 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 9.5099999999999998 111.396 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -135.75 153.83 77.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.196 -0.456 . . . . 11.539999999999999 110.802 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.63 147.93 89.79 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.494 2.129 . . . . 8.6600000000000001 112.07 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.615 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -150.15 167.54 26.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 5.2199999999999998 111.321 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 2.4 m -132.64 118.91 19.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 6.8300000000000001 110.864 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.77 HD12 ' HB3' ' A' ' 96' ' ' ASP . 59.7 mt -59.01 101.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 6.7000000000000002 111.412 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.75 -35.66 15.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 8.7699999999999996 111.425 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.52 152.55 33.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.433 -0.349 . . . . 9.1999999999999993 110.904 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.606 HD11 HG21 ' A' ' 113' ' ' ILE . 66.8 mt -137.65 150.55 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 10.640000000000001 111.247 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -126.74 89.84 3.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.855 -0.611 . . . . 11.56 110.319 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -68.64 -25.98 65.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.698 -0.683 . . . . 14.24 111.103 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -48.63 -68.39 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.326 -0.397 . . . . 16.870000000000001 110.216 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 27.7 mtp85 -84.51 -90.74 0.09 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.18 -0.463 . . . . 15.09 110.243 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 176.86 55.6 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.327 -0.397 . . . . 13.609999999999999 110.848 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.98 175.0 9.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.848 0.356 . . . . 9.5700000000000003 111.942 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.498 ' SG ' HD11 ' A' ' 141' ' ' LEU . 8.7 p -172.03 135.92 0.84 Allowed 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.907 -0.588 . . . . 6.8200000000000003 110.722 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 90.0 t -90.13 139.87 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.229 -0.441 . . . . 6.5 111.377 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 6.7 m -130.14 150.11 34.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 110.984 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 t -106.09 134.45 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 7.5300000000000002 111.017 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.475 ' HB3' ' HD2' ' A' ' 130' ' ' TYR . 8.8 m-85 -79.22 105.78 10.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.091 0.472 . . . . 8.5899999999999999 111.04 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.46 116.44 4.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.762 -0.653 . . . . 10.27 111.631 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.85 -25.08 28.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.728 . . . . 12.41 113.441 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.475 ' HD2' ' HB3' ' A' ' 127' ' ' TYR . 75.8 m-85 -95.58 -22.81 17.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.793 0.297 . . . . 11.49 111.297 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.83 -9.68 6.17 Favored Glycine 0 CA--C 1.517 0.201 0 C-N-CA 120.818 -0.706 . . . . 10.07 112.854 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -80.17 156.62 26.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.621 0.248 . . . . 8.5800000000000001 110.62 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.6 ttp180 -128.34 140.51 51.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.93 0.395 . . . . 9.3499999999999996 111.12 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -148.69 155.8 41.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 5.8099999999999996 110.732 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -97.55 148.59 23.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.415 . . . . 7.8600000000000003 111.213 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -143.17 175.83 9.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.976 -0.557 . . . . 5.8600000000000003 110.687 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.04 143.38 31.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.901 0.381 . . . . 8.9199999999999999 111.195 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 141' ' ' LEU . 1.2 mt -58.73 -43.08 90.11 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 8.9499999999999993 111.139 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 6.6 m -65.19 -17.52 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 10.26 111.042 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.01 7.81 34.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.274 -0.421 . . . . 8.3000000000000007 111.248 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.498 HD11 ' SG ' ' A' ' 123' ' ' CYS . 38.1 mt -74.9 131.73 40.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 5.4699999999999998 110.831 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 0.9 OUTLIER -106.34 158.49 16.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.174 -0.467 . . . . 6.9199999999999999 111.061 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.53 ' HB2' ' HD2' ' A' ' 144' ' ' PRO . 60.3 p -86.35 161.27 49.31 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 6.0700000000000003 110.632 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.53 ' HD2' ' HB2' ' A' ' 143' ' ' SER . 5.6 Cg_endo -47.75 131.59 20.41 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.789 2.326 . . . . 7.04 112.242 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.2 pt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 115.939 -0.573 . . . . 9.9399999999999995 111.602 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.428 HE21 ' HB3' ' A' ' 90' ' ' GLN . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.751 0.31 . . . . 10.470000000000001 110.736 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -68.14 135.24 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 11.4 110.741 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -89.41 131.46 35.46 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.308 -0.405 . . . . 8.5999999999999996 111.198 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -146.38 175.9 10.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.042 -0.527 . . . . 12.390000000000001 110.803 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 114' ' ' ALA . 3.0 t -65.38 129.81 29.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 10.15 110.961 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.94 73.6 1.03 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.731 -0.747 . . . . 8.1999999999999993 112.196 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.436 ' O ' HD12 ' A' ' 113' ' ' ILE . 2.9 m-20 -152.98 133.7 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.826 0.346 . . . . 6.8099999999999996 110.762 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 43.9 mmtt -76.75 115.16 16.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 9.0999999999999996 111.038 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 142' ' ' LEU . 15.9 p -135.48 -158.76 0.9 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 4.46 110.895 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 49.5 m -141.09 146.0 36.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.956 0.408 . . . . 5.7599999999999998 110.772 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.35 153.34 41.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.183 -0.462 . . . . 5.4699999999999998 111.151 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 mp -92.3 145.45 7.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 8.1600000000000001 111.088 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -92.43 151.43 20.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.456 . . . . 9.9499999999999993 110.849 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.2 m -92.11 7.46 42.32 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 9.2400000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -90.51 -60.94 1.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 11.5 110.901 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -111.13 -11.19 14.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.324 -0.398 . . . . 12.93 111.011 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 73.57 53.45 7.42 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.769 -0.729 . . . . 11.27 112.648 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 68.5 m -132.62 159.65 38.94 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.819 0.343 . . . . 12.07 110.791 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.81 131.32 35.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 9.5099999999999998 111.617 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.25 149.41 65.76 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 11.539999999999999 110.548 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.483 ' HG2' ' OG1' ' A' ' 128' ' ' THR . 12.9 Cg_endo -58.22 142.5 97.35 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.309 2.006 . . . . 8.6600000000000001 111.929 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.59 174.2 12.81 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.261 -0.427 . . . . 5.2199999999999998 111.442 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.4 m -137.61 119.15 14.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.966 -0.561 . . . . 6.8300000000000001 111.017 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.549 HG21 HD11 ' A' ' 116' ' ' ILE . 3.6 mt -64.05 114.89 2.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.245 -0.434 . . . . 6.7000000000000002 111.518 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 94' ' ' VAL . . . -95.04 -38.03 10.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.963 -0.562 . . . . 8.7699999999999996 111.934 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 11.2 t -151.48 151.47 31.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.926 0.393 . . . . 9.1999999999999993 111.251 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.561 HG23 HD11 ' A' ' 138' ' ' LEU . 81.6 mt -137.55 145.51 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.006 -0.543 . . . . 10.640000000000001 111.065 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.13 134.41 49.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 11.56 110.627 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.05 17.13 19.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.129 -0.487 . . . . 14.24 111.187 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.97 -62.61 1.44 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 16.870000000000001 110.629 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.31 20.6 18.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.057 -0.52 . . . . 15.09 110.491 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 50.28 68.34 0.77 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.803 -0.635 . . . . 13.609999999999999 110.643 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 68.3 p -136.25 174.86 10.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 9.5700000000000003 111.258 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.555 ' SG ' ' HG ' ' A' ' 138' ' ' LEU . 1.6 p -168.72 135.1 1.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.881 -0.6 . . . . 6.8200000000000003 110.589 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 70.5 t -91.13 131.37 38.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.396 -0.365 . . . . 6.5 110.712 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 134' ' ' GLU . 18.4 m -123.83 143.86 35.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 4.1900000000000004 111.462 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HG2' ' A' ' 133' ' ' ARG . 42.2 t -110.46 130.63 63.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.954 -0.566 . . . . 7.5300000000000002 110.501 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -74.85 136.66 41.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.813 0.339 . . . . 8.5899999999999999 110.619 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.483 ' OG1' ' HG2' ' A' ' 110' ' ' PRO . 2.2 p -53.47 -88.38 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.095 -0.502 . . . . 10.27 111.771 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.47 26.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.967 -0.635 . . . . 12.41 112.805 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -48.37 -43.13 33.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.802 0.334 . . . . 11.49 111.282 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 80.26 -26.05 3.06 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.799 -0.715 . . . . 10.07 113.043 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -59.11 147.68 34.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.338 . . . . 8.5800000000000001 110.895 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HG2' HG22 ' A' ' 126' ' ' VAL . 4.6 mtp85 -99.61 155.64 17.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 9.3499999999999996 110.815 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.437 ' O ' HG22 ' A' ' 125' ' ' VAL . 4.2 mm-40 -159.61 128.14 5.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 5.8099999999999996 110.835 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -80.95 125.77 30.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.283 -0.417 . . . . 7.8600000000000003 111.127 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.74 172.86 11.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 5.8600000000000003 110.606 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.52 142.41 32.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 8.9199999999999999 111.101 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.561 HD11 HG23 ' A' ' 116' ' ' ILE . 1.0 OUTLIER -58.42 -40.34 82.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.2 -0.454 . . . . 8.9499999999999993 111.067 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -12.73 60.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.249 -0.432 . . . . 10.26 111.022 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -110.03 -1.66 17.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.297 -0.41 . . . . 8.3000000000000007 111.101 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.51 143.13 53.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.329 -0.396 . . . . 5.4699999999999998 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 98' ' ' CYS . 0.9 OUTLIER -112.91 170.46 8.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.236 -0.438 . . . . 6.9199999999999999 111.057 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.64 159.39 41.04 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.004 -0.544 . . . . 6.0700000000000003 110.608 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.4 56.33 5.48 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.585 2.19 . . . . 7.04 112.614 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 16.3 mt . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.356 -0.384 . . . . 9.9399999999999995 111.5 179.825 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.735 0.303 . . . . 10.470000000000001 111.41 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 50.63 -151.75 0.2 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.203 -0.453 . . . . 11.4 111.237 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 55.4 m95 -149.01 128.22 12.86 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.276 -0.42 . . . . 8.5999999999999996 110.931 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.71 160.11 41.3 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 12.390000000000001 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 94' ' ' VAL . 4.0 t -56.27 135.13 20.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.213 -0.449 . . . . 10.15 110.994 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 77.44 72.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.843 -0.694 . . . . 8.1999999999999993 111.847 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.609 ' HB3' HD12 ' A' ' 113' ' ' ILE . 0.5 OUTLIER -151.04 131.18 13.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.828 0.347 . . . . 6.8099999999999996 110.98 -179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 103.4 3.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.037 -0.529 . . . . 9.0999999999999996 110.806 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.9 p -121.9 -169.04 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 4.46 110.863 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.464 ' HB2' ' HB2' ' A' ' 142' ' ' LEU . 3.6 m -135.3 135.76 41.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.507 . . . . 5.7599999999999998 110.716 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -135.34 148.77 49.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.308 -0.405 . . . . 5.4699999999999998 111.428 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.444 ' HA ' ' O ' ' A' ' 107' ' ' CYS . 3.6 mt -83.18 138.77 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.932 -0.576 . . . . 8.1600000000000001 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -88.8 135.81 33.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 9.9499999999999993 110.871 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.55 35.63 0.56 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.112 -0.495 . . . . 9.2400000000000002 111.054 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -126.51 -30.74 2.81 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 11.5 110.772 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -12.86 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.061 -0.518 . . . . 12.93 110.694 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 66.88 62.88 4.18 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.921 -0.656 . . . . 11.27 112.4 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 101' ' ' ILE . 1.0 OUTLIER -140.11 166.03 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.887 0.375 . . . . 12.07 111.008 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.4 mt -84.93 123.96 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 9.5099999999999998 111.412 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.89 150.28 72.85 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.241 -0.436 . . . . 11.539999999999999 110.861 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.11 137.6 80.3 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.515 2.143 . . . . 8.6600000000000001 112.151 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.607 ' HB1' ' HB ' ' A' ' 125' ' ' VAL . . . -141.3 162.57 35.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 5.2199999999999998 111.315 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.79 114.49 11.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.04 -0.527 . . . . 6.8300000000000001 110.643 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.609 HD12 ' HB3' ' A' ' 96' ' ' ASP . 11.3 mt -59.2 109.72 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.289 -0.414 . . . . 6.7000000000000002 111.534 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.48 -40.89 10.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.493 . . . . 8.7699999999999996 111.398 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.49 147.58 31.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.502 -0.317 . . . . 9.1999999999999993 110.876 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 113' ' ' ILE . 78.5 mt -131.3 139.96 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.323 -0.399 . . . . 10.640000000000001 111.376 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -126.66 133.13 51.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.996 -0.547 . . . . 11.56 110.11 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.0 11.23 34.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 14.24 111.286 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -71.75 0.22 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.276 -0.42 . . . . 16.870000000000001 110.57 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER -114.8 31.72 6.47 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 15.09 110.835 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 52.48 74.03 0.3 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.988 -0.551 . . . . 13.609999999999999 110.95 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.8 p -142.99 172.99 11.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 9.5700000000000003 111.317 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . 0.419 ' SG ' HD11 ' A' ' 141' ' ' LEU . 0.8 OUTLIER -165.48 167.59 17.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.024 -0.535 . . . . 6.8200000000000003 110.927 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.06 101.06 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 6.5 110.542 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.607 ' HB ' ' HB1' ' A' ' 111' ' ' ALA . 20.5 m -96.53 138.07 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 4.1900000000000004 111.593 -179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 17.9 t -103.06 130.75 52.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.951 -0.568 . . . . 7.5300000000000002 110.5 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 130' ' ' TYR . 41.9 m-85 -74.89 106.67 6.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.088 0.471 . . . . 8.5899999999999999 110.837 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.17 95.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.775 -0.648 . . . . 10.27 111.66 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.41 4.77 15.29 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.505 -0.855 . . . . 12.41 113.07 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' A' ' 127' ' ' TYR . 59.3 m-85 -125.08 -20.79 4.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.736 0.303 . . . . 11.49 111.075 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 61.64 37.84 94.89 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.737 -0.744 . . . . 10.07 112.519 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -129.66 146.35 51.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.653 0.263 . . . . 8.5800000000000001 110.61 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.9 mtp180 -108.62 142.3 39.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.455 -0.338 . . . . 9.3499999999999996 110.684 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -149.32 129.92 14.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 5.8099999999999996 110.953 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -84.61 133.31 34.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.002 -0.545 . . . . 7.8600000000000003 110.993 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -137.3 176.02 9.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 5.8600000000000003 110.741 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -96.88 139.19 33.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.301 -0.409 . . . . 8.9199999999999999 110.76 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.4 mt -57.95 -36.66 72.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 8.9499999999999993 111.176 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.6 -13.34 60.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 10.26 111.278 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.3 10.42 23.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.344 -0.389 . . . . 8.3000000000000007 111.046 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.419 HD11 ' SG ' ' A' ' 123' ' ' CYS . 42.3 mt -79.03 130.62 35.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.41 . . . . 5.4699999999999998 110.918 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 99' ' ' SER . 7.5 mt -92.16 155.05 18.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.132 -0.485 . . . . 6.9199999999999999 110.821 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.03 152.65 41.55 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 6.0700000000000003 110.997 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -162.59 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.581 2.187 . . . . 7.04 112.37 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 18.6 tt . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 9.9399999999999995 111.025 179.929 . . . . . . . . 0 0 . 1 stop_ save_